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Abstract 
 
Background: It is unknown whether a conservative approach to fluid administration or deresuscitation 
(active removal of fluid using diuretics or renal replacement therapy (RRT)) is beneficial following 
haemodynamic stabilisation of critically ill patients. 
 
Purpose: To evaluate the efficacy and safety of conservative or deresuscitative fluid strategies in adults 
and children with acute respiratory distress syndrome (ARDS), sepsis, or systemic inflammatory response 
syndrome (SIRS) in the post-resuscitation phase of critical illness. 
 
Methods: We searched Medline, EMBASE, and the Cochrane central register of controlled trials from 1980 
to June 2016, and manually reviewed relevant conference proceedings from 2009 to the present.  Two 
reviewers independently assessed search results for inclusion and undertook data extraction and quality 
appraisal.  We included randomised trials comparing fluid regimens with differing fluid balances between 
groups, and observational studies investigating the relationship between fluid balance and clinical 
outcomes.  
 
Results: 49 studies met inclusion criteria.  Marked clinical heterogeneity was evident.  In a meta-analysis 
of 11 randomised trials (2051 patients) using a random effects model, we found no significant difference in 
mortality with conservative or deresuscitative strategies compared to a liberal strategy or usual care 
(pooled risk ratio [RR] 0.92, 95% confidence interval [CI] 0.82-1.02, I2=0%). A conservative or 
deresuscitative strategy resulted in increased ventilator-free days (mean difference 1.82 days, 95% CI 0.53 
to 3.10 days, I2=9%) and reduced length of ICU stay (mean difference -1.88 days, 95% CI -0.12 to -3.64 
days, I2=75%) compared to a liberal strategy or standard care. 
 
Conclusions: In adults and children with ARDS, sepsis or SIRS, a conservative or deresuscitative fluid 
strategy results in increased number of ventilator-free days and decreased length of ICU stay compared 
with a liberal strategy or standard care.  The effect on mortality remains uncertain.  Large randomised trials 
are needed to determine optimal fluid strategies in critical illness. 
 
Keywords: Fluid therapy; Diuretics; Water-electrolyte balance; Critical Illness; Sepsis; Respiratory Distress 
Syndrome, Adult; Systemic Inflammatory Response Syndrome. 
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Background 
 
Optimising fluid status is a fundamental concern of critical care practice.  Ample data suggest that the 
optimisation of intravascular volume status can increase cardiac output and global oxygen delivery, and 
large volumes of intravenous fluids are often administered for this purpose.  In addition, critically ill patients 
frequently receive large volumes of fluid as drug diluents, as artificial nutrition, and as maintenance fluid. 
 
In the face of increased capillary permeability, sodium and water retention, and acute kidney injury (AKI), all 
of which are common in critical illness, the accumulation of large volumes of fluid in the interstitium is a 
frequent occurrence and may impair oxygen delivery at the cellular level.  Clinically this fluid overload is 
apparent as peripheral and pulmonary oedema, although other organs may be affected [1].  A number of 
cohort studies have demonstrated an association between fluid overload and mortality [2-4], and it has 
been suggested that strategies aimed at prevention or treatment of fluid overload may be beneficial 
following haemodynamic stabilisation [5].   
 
A previous systematic review and meta-analysis on the topic of fluid overload and the relationship between 
fluid balance and mortality [6] in critically ill patients reported studies with considerable heterogeneity in 
design, presence of comparator groups, populations, as well as the timing and nature of interventions.  By 
narrowing our focus to specific populations, and by including but not attempting to meta-analyse 
observational studies, we aimed to maximise both the external and internal validity of our review. 
 
The aim of this review is to evaluate the impact of a conservative fluid or active deresuscitation strategy 
compared with standard care or a liberal fluid strategy in critically ill adult or paediatric patients with sepsis, 
systemic inflammatory response syndrome (SIRS), or acute respiratory distress syndrome (ARDS) on 
mortality and other clinical outcomes.  Secondary aims were to identify criteria used to judge suitability for 
conservative fluid management or deresuscitation; to describe the interventions used to minimise fluid 
intake or deresuscitate patients, and to identify contraindications to deresuscitation or conservative fluid 
management in published studies. 
 
Methods 
 
The protocol for this review was prospectively registered with PROSPERO (International prospective 
register of systematic reviews; CRD42013005608) and published previously [7].  We used Cochrane review 
methodology [8] in protocol development and review conduct, and adhered to the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [9] in reporting the review. 
 
Search strategy 
  
MEDLINE, EMBASE and the Cochrane Central register of controlled trials (CENTRAL) were searched (up 
to 24th June, 2016) for potentially relevant studies without language constraints.  In addition, we manually 
searched indexed abstracts from the American Thoracic Society, Society of Critical Care Medicine, and 
European Society of Intensive Care medicine annual congresses and the International Symposium on 
Intensive Care and Emergency Medicine from 2009 to the present.  A full list of MEDLINE search terms is 
available as an appendix to the published protocol [7].   
 
Inclusion and exclusion criteria 
 
We included randomised and quasi-randomised clinical trials of adult or paediatric patients with ARDS, 
SIRS or sepsis in which two or more fluid strategies were compared and in which fluid balance differed 
between groups; and observational studies in which the relationship between fluid balance and clinical 
outcomes in ARDS, SIRS or sepsis was the major focus of the study.   
 
We excluded studies that focused only on the resuscitation phase of critical illness, and studies in which 
fluids were only one element of a complex haemodynamic strategy. We also excluded case series, case 
reports, observational studies with fewer than 50 participants, studies published prior to 1980, studies 
involving predominantly neonates, post-cardiac surgery patients, or patients with heart failure, and studies 
subject to post-publication retraction or investigation. 
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Selection of studies and data extraction 
 
Titles and abstracts of all reports identified in the literature searches were screened by two of three authors 
(JS, EEM and AF) for further review with discrepancies resolved by consensus.  Full text review of eligibility 
was conducted by two authors independently (JS and EM) and relevant data extracted in duplicate from 
included studies to a standard piloted form [7].  Discrepancies were resolved by discussion and 
adjudication by a third author (EF).  Where relevant, attempts were made to contact authors of randomised 
studies for missing data.  The reference lists of included randomised trials were reviewed for additional 
trials meeting eligibility criteria. 
 
Outcome measures 
 
The primary outcome was all-cause mortality at the latest time point available up to 90 days.  Key 
secondary outcomes included ventilator-free days (VFDs), length of intensive care unit (ICU) stay, 
incidence of AKI, renal replacement therapy (RRT) use, and cognitive impairment.   
 
Risk of bias assessment 
 
Two authors (JS and EM) independently assessed risk of bias and quality. Randomised controlled trials 
were assessed as being at low, uncertain or high risk of bias for each of 6 domains using the Cochrane risk 
of bias tool [8].  Cohort and case-control studies were assessed for quality using the Newcastle Ottawa 
scale [10] (Appendix 2). 
 
Analysis 
 
RevMan software [8] was used to carry out meta-analysis using a random effects model for outcomes for 
which two or more randomised studies were available. Results for outcomes for which meta-analysis was 
deemed inappropriate because of an insufficient number of studies or clinical or statistical heterogeneity 
were reported in narrative form, and observational studies were reported in tabular form (Appendix 1). 
Where necessary to standardise reporting of central tendency between studies, we converted standard 
error to standard deviation, and estimated mean and standard deviation from reported median and 
interquartile ranges using a standard approach [11].  For key outcomes, we assessed the quality of 
evidence using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) 
approach [12]. 
 
We undertook a pre-planned sensitivity analysis excluding studies at high risk of bias, and subgroup 
analyses for ARDS, sepsis or SIRS, and adults.  We also undertook a post-hoc analysis in which we 
excluded studies lacking a clinically-significant difference in fluid balance between groups, which we 
defined as a minimum difference in mean or median fluid balance of 750 mL per day for adults or 10 
mL/kg/day for children.  We also carried out a meta-regression analysis with difference in mean daily fluid 
balance as the independent, and risk ratio (RR) for mortality as the dependent variable. 
 
Results 
 
The search was conducted up to 24 June 2016 and during the editorial process we obtained one further 
study in press from the editor. Forty-nine studies met criteria for inclusion.  Of these, 11 randomised 
controlled trials, recruiting a total of 2051 patients, provided data for meta-analysis. The remaining 38 
studies were observational in design and are summarised in Appendix 1.  The Newcastle-Ottawa score for 
observational studies is reported in Appendix 2.   Secondary publications from included studies are 
reported along with the original study [13-15]. A summary of evidence is found in Table 2. 
 
Description of included randomised trials 
 
Considerable clinical heterogeneity was present.  Five studies [16-20] took place in the United States, three 
in China [21-23], one in France  [24] one in India [25] and one in Denmark and Finland [26].  Sample sizes 
ranged from 29 [21] to 1000 [16].  One was conducted in children [25] and the remainder in adults.  Five 
studies included only patients with ARDS [16-18, 21, 22], four included only patients with septic shock [19, 
24-26]; one included patients with ARDS, septic shock, or both [23] and one included a mixed critically ill 
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population, the majority of whom had sepsis, ARDS, or both [20].  Further characteristics of included 
randomised trials are presented in Table 1.   
 
Methodological quality and risk of bias 
 
The overall quality of included randomised trials was moderate (Figure 2). The use of random sequence 
generation and allocation concealment [19-22, 25] and the risk of reporting bias [18, 20-22, 25] were 
unclear in a number of studies. While blinding was used in only 2 studies [17, 18], likely due to difficulties in 
concealment of the different fluid regimens and/or haemodynamic monitoring technologies employed, strict 
protocolisation of fluid and diuretic use was felt to ameliorate the effects of this potential bias in all but two 
studies [19, 21]. 
 
Mortality (primary outcome) 
 
Eleven studies (2051 patients) reported mortality as an outcome with variable duration of follow-up, 
including 90-day [26], 60-day [16, 21, 22], in-hospital [19, 20] and 28 or 30-day mortality [17, 18, 23-25]. We 
found no significant difference in mortality between patients receiving a conservative or deresuscitative fluid 
strategy compared with those receiving a liberal strategy or standard care (pooled RR 0.92; 95% 
confidence interval [CI] 0.82-1.02, I2=0%) (Figure 3).   
 
One trial [16] accounted for the majority of patients in the ARDS subgroup, and the results for this subgroup 
(5 studies, n=1206, pooled RR 0.91; 95% CI 0.77-1.07) were similar to those in the overall analysis.  In the 
sepsis/SIRS subgroup, three trials were conducted in adults [19, 24, 26] and one in children [25].  Results 
from this subgroup analysis were also similar to those in the overall analysis (394 patients, pooled RR 0.86; 
95% CI 0.62-1.17) (Figure 3).   
 
Secondary outcomes 
 
Ventilator-free days 
Data on the number of VFDs within a 28 or 30-day period were available for seven studies, including 1784 
participants (Figure 4). We found increased VFDs with a conservative or deresuscitative fluid strategy in 
comparison with a liberal strategy or standard care (mean difference 1.82 days [95% CI interval 0.53 to 
3.10 days], I2=9%).  In addition, studies by Hu et al [21] and Wang et al [22] reported shorter duration of 
mechanical ventilation in a more conservative fluid strategy group compared with the liberal fluid strategy 
group (10.13 +/- 3.02 days vs. 12.64 +/- 2.89, P<0.05 and 9.62 +/- 2.55 days vs 12.51 +/-2.92 days, P<0.05 
respectively). 
 
Length of ICU stay 
Nine studies reported the duration of ICU admission of which seven were suitable for meta-analysis (Figure 
5). We found a shorter length of ICU stay in patients receiving a conservative or deresuscitative fluid 
strategy compared with those receiving a liberal strategy or standard care (mean difference 1.88 days 
fewer (95% CI -0.12 to -3.64 days).  Considerable heterogeneity was present (I2=75%).  Two studies in 
ARDS patients reported a composite outcome of ICU-free days: Martin et al [18] reported a numerically 
greater number of ICU-free days in the fluid conservative group (median 1.5 days greater, 95% CI -3.4 to 
+6.4 days), while in the Fluids and Catheter Treatment Trial (FACTT) [16], a conservative strategy resulted 
in a significantly greater number of ICU-free days compared to a liberal strategy (13.4 +/- 8.97 versus 11.2 
+/- 8.92, P<0.001). 
 
Length of Hospital stay 
One study [18] reported no significant reduction in the length of hospital stay for survivors of ARDS with a 
deresuscitative strategy (median 4.5 fewer days in hospital, 95% CI -5.8 to 14.8 days).   
 
Organ dysfunction scores 
Martin et al [17] reported a fall in mean Sequential Organ Failure Assessment (SOFA) score of 0.6 with a 
deresuscitation strategy compared with an increase of 1.1 in the control group over the 5 day study period 
(P=0.01).  Zhang et al [23] reported higher maximum SOFA scores in the more conservatively managed 
group, although this difference was also present at baseline; and Richard et al [24] reported similar duration 
of SOFA score ≥ 6. 
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Long-term mortality 
No studies reported long-term (>90 day) mortality as an outcome. 
 
Incidence of ARDS 
No studies reported incidence of ARDS as an outcome. 
 
Incidence of Acute Kidney Injury  
Martin et al [18] reported no difference in change in serum creatinine between patients in a deresuscitation 
group compared with placebo, while in the FACTT study [16] the incidence of AKI was similar between 
conservative and liberal fluid management groups (21.5 +/- 11.21 renal failure free days versus 21.2 +/- 
11.15, P=0.59).  Hjortrup et al [26] reported a lower incidence of worsening of AKI in a conservative fluid 
group than with standard care (37% versus 54%, P=0.03). In separate post-hoc analyses of the FACTT 
study, Liu and colleagues showed that after correcting serum creatinine levels for fluid balance, AKI 
incidence was lower with a conservative than with a liberal fluid strategy [14]; and Grams et al reported that 
in patients with AKI, cumulative diuretic dose was independently associated with lower mortality [15]. 
 
Renal replacement therapy use 
In three studies [16, 19, 26] (1233 patients), the rate of RRT use was similar between patients receiving a 
conservative fluid or deresuscitative strategy compared with a liberal fluid strategy or standard care (RR 
0.88; 95% CI 0.64-1.22, I2=27%) (Appendix 3.5).  Zhang et al [23] reported fewer days free of continuous 
RRT in the conservative fluid strategy group (median 15.5 days [IQR 3-28] versus 21 [4-28], P<0.05). 
 
Cognitive function 
In a cohort of seventy-five survivors from FACTT [16] who underwent follow up assessment of cognitive 
function, Mikkelsen et al [13] identified enrolment in the conservative fluid management arm as an 
independent risk factor for cognitive impairment at twelve months post hospital discharge.  In contrast, 
Wang and colleagues [22] assessed post-ICU cognitive function as one component of the QLQ-C30 quality 
of life score, and found better cognitive function scores in patients treated with a conservative fluid strategy 
than a liberal fluid strategy (85.02 +/- 15.06 vs. 74.31 +/-12.88, P<0.05). 
 
Additional analyses 
 
Additional sensitivity and subgroup analyses are found in Appendix 3. 
 
Readiness for conservative fluid management or deresuscitation 
 
The majority of studies did not attempt to use specific physiological or time criteria to determine readiness 
for conservative fluid management or deresuscitation. One study [19] postponed initiation of a conservative 
fluid management strategy until patients were demonstrated to be volume unresponsive. Fluid minimisation 
occurred between one and four days post-randomisation, however clinically-significant separation of fluid 
balance between groups was not achieved over five days. 
 
Interventions 
 
There was considerable variation in fluid strategies applied and fluid balances achieved in both 
conservative / deresuscitative and liberal / standard care groups.   In three studies [16-18], protocolised 
diuretic use was used in the conservative / deresuscitative arm, in four the intervention strategy involved 
protocolised fluid restriction or minimisation [16, 19, 25, 26]; and in five the main intervention was the use of 
alternative haemodynamic targets for fluid management, based on extravascular lung water (EVLW) [20-
22], pulse pressure variation (PPV) [24], or intrathoracic blood volume index (ITBVI) [23].  In two trials 
hyperoncotic albumin infusions were used to potentiate diuresis in a deresuscitative group [17, 18].  Fluid 
strategies in study control arms included protocolised liberal fluid administration [16], protocolised diuretic 
use without hyperoncotic albumin [17] and central venous pressure (CVP) or pulmonary capillary wedge 
pressure (PCWP)-guided fluid administration [20, 21, 23, 24]. 
 
As a result of variability in fluid strategies used, there was wide variation in fluid balances and considerable 
overlap between conservative and liberal groups.  For example, in the study by Martin et al [17] the ‘liberal’ 
group received diuretics and achieved a weight loss of 4700 mL over five days, equating to an estimated 
mean fluid balance of -22.4 mL/kg/day; while in the study by Chen and Kollef [19], a targeted fluid 
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minimisation strategy in the conservative arm yielded a median positive fluid balance of 2641 mL over five 
days, equating to a positive mean fluid balance of 7.5 mL/kg/day. 
 
Contraindications to deresuscitative fluid management 
 
Two studies of deresuscitation [17, 18] excluded patients with AKI, those with more than a minimal 
requirement for vasopressors, and those with uncorrected hypernatraemia or hypokalaemia. 
Deresuscitation was suspended if hypotension, hypernatraemia or hypokalaemia developed during the 
intervention period, and fluid boluses were given at the discretion of the clinical team.  In FACTT [16], fluid 
administration and diuretic use was protocolised, so that haemodynamic insufficiency triggered fluid bolus 
administration or vasoactive medication use, and diuretics were withheld in the presence of AKI. 
 
Observational studies 
 
We included a total of 38 observational studies in this review; characteristics are reported in appendix 1.  
The majority were cohort studies in which fluid balance was compared between survivors and non-
survivors of critical illness, with or without adjustment for severity of illness and other potential confounders.  
The majority of observational studies were assessed as moderate or low quality using the Newcastle-
Ottawa scale (Appendix 2).   
 
The main finding was a consistent positive association between more positive fluid balance and higher 
mortality [3, 4, 27-52] which was present within all pre-specified subgroups: adults [3, 4, 28, 30-33, 36-38, 
40-46, 48, 50-53], children [27, 29, 35, 49], ARDS [3, 32, 35, 39, 40, 43, 46, 48, 49] and sepsis [4, 27-31, 
33-38, 40-42, 44, 45, 50-53].  This association was absent or present only in subgroups in seven studies in 
which mortality was reported as an outcome [54-60].  One study reported a lower mortality with greater fluid 
administration and more positive fluid balance over 3 days [61].  A more positive fluid balance was 
associated with increased [32, 55] or similar [29, 42] duration of mechanical ventilation, fewer ventilator-free 
days [35, 54, 56, 60] and increased [32, 52, 60] or similar [42, 55] length of ICU stay.  Rates of AKI or RRT 
use were similar [29, 33, 56, 59, 61, 62] or higher [36, 60] with a more positive fluid balance. 
 
Discussion 
 
Although reference is made in current guidelines to the use of intravenous fluid for resuscitation in sepsis 
[63], fluid management goals following the resuscitation phase of critical illness remain the subject of 
considerable uncertainty. Our review evaluated the efficacy and safety of a conservative or deresuscitative 
fluid strategy compared with standard care or a liberal fluid strategy in critically ill patients with sepsis, 
SIRS, or ARDS. 
 
We found no clear evidence for the superiority of one fluid strategy over another for our primary outcome of 
mortality.  This is in contrast to a previous meta-analysis [6], and likely reflects our exclusion of 
observational data from our meta-analysis.  We found that a conservative or deresuscitative fluid strategy 
resulted in a greater number of VFDs and decreased length of ICU stay than a liberal fluid strategy or 
standard care, with no increase in acute kidney injury, use of RRT, or cognitive dysfunction.  When we 
excluded those studies in which we considered inter-group differences in fluid balance to be clinically 
unimportant, we found a non-significant reduction in mortality with conservative or deresuscitative fluid 
management (Appendix 3.3).  The quality of evidence was low or very low across all outcomes. 
 
We found no difference in rates of renal replacement therapy use between fluid strategies. Along with post-
hoc analyses of the FACTT study showing a reduced incidence of AKI with a conservative fluid strategy 
[14] and a protective effect of diuretic use [15], this provide reassurance as to the safety of a conservative 
or deresuscitative approach to fluid management in terms of renal outcomes. 
 
The effect of a conservative fluid strategy or deresuscitation in terms of cognitive outcomes is unclear, with 
a secondary analysis of a small cohort of patients from the FACTT study showing evidence of harm from a 
conservative approach [13]. This contrasts with the findings of Wang and colleagues in which post-ICU 
discharge cognitive function was improved in a conservative fluid management group [22], and those of a 
small randomised trial in patients undergoing major vascular surgery where a conservative fluid strategy 
was associated with a reduction in post-operative complications including delirium [64], a clinical outcome 
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known to be associated with longer term cognitive dysfunction [65]. This merits further investigation in 
future trials investigating fluid strategy. 
 
Our review has a number of strengths.  It was conducted using high quality systematic review methodology. 
A highly sensitive search strategy was developed which was independently reviewed by a second 
information specialist.  In order to minimise bias, no language restrictions were employed, and broad date 
criteria were applied.  At least two reviewers were involved independently at each stage of the review 
process, and all studies were evaluated for quality and risk of bias.   
 
There are a number of important limitations in this review, however. Even in the small number of studies 
included, considerable heterogeneity was evident with respect to study populations, interventions, and 
outcomes. Due to lack of standardised definitions, the timing and duration of the ‘post-resuscitation’ 
intervention period varied between studies, although the available data did not allow in-depth exploration of 
this issue.  This highlights the need to standardise these definitions for future clinical trials.  Because of 
insufficient data, we were unable to separate the differential impact of restrictive fluid administration and 
active deresuscitation.  Some of the interventions employed resulted in minimal separation between groups 
in fluid balance. As we did not define what constituted a clinically-significant difference in fluid balance 
between groups a priori, we included all in our main analysis (Figure 3) but undertook a sensitivity analysis 
in which studies were excluded on the basis of clinically insignificant differences in fluid balance between 
groups (Appendix 3.3).    
 
There was considerable inconsistency in reporting which precluded some studies for inclusion in meta-
analyses, exemplified by some studies reporting duration of mechanical ventilation with others reporting a 
composite outcome of ventilator-free days. This is a recognised problem in studies of patients receiving 
mechanical ventilation  [66]. Even for the uniformly reported outcome of mortality, there was variability in 
the duration of follow-up from 28 to 90 days, although this is unlikely to have had a major impact on 
summary estimates of effect [67]. 
 
We limited our review to patients with sepsis, SIRS and ARDS.  The inevitable consequence is a loss of 
generalizability to other types of critically ill patients, although since these are common syndromes rather 
than specific diagnoses, and since patients admitted to ICU with a range of pathologies (e.g. traumatic 
brain injury [68] and polytrauma [69]) frequently develop SIRS, ARDS and sepsis, the generalizability of 
these findings is likely go beyond simply those patients who meet rigidly applied consensus criteria. 
 
We identified a large number of observational studies in which fluid accumulation or overload was 
associated with worse outcomes, particularly mortality.  The potential for residual confounding is present to 
some extent in all of these, in that greater cumulative fluid balances may reflect greater severity of illness 
and greater perceived or actual need for fluid resuscitation or clinician reluctance to either withhold fluid or 
to administer diuretics to more severely ill patients. 
 
Robust multicentre trials are needed to evaluate the effectiveness of restrictive fluid administration, 
deresuscitation or a combined fluid strategy to improve patient outcomes.  Based on our data, a sample 
size of over 4700 patients would be required to detect or exclude a significant mortality benefit for a 
conservative and/or deresuscitative fluid strategy (Appendix 3.3).  However, the heterogeneity illustrated in 
this review highlights the need for considerable further pilot work to define the optimal intervention strategy 
or strategies to be subsequently tested in high-quality, adequately powered multicentre randomised trials.  
Pilot studies should, for example, address the questions of physiological or other criteria to define the 
appropriate timing for conservative fluid management, the utility of deresuscitation in addition to fluid 
restriction alone, the comparative benefits and harms of ultrafiltration and diuretics, and the use of 
adjunctive hypertonic albumin among others. 
 
Conclusions 
 
Despite a considerable body of observational evidence showing a positive association between fluid 
balance and mortality, our review found no significant difference in mortality from included randomised trials 
addressing the question of optimal fluid strategy for critically ill patients. We found that a conservative or 
deresuscitative approach resulted in increased ventilator-free days and decreased length of ICU stay 
compared to a liberal strategy or standard care.   
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Large robust trials are needed in which clear inter-group differences in fluid balance are present to evaluate 
the efficacy and safety of a conservative or deresuscitative fluid strategy in terms of both short and long 
term outcomes. The optimum strategy to be tested in such trials remains to be defined.  Meanwhile, 
clinicians caring for critically ill patients may consider the use of a conservative fluid management strategy 
in patients with sepsis, ARDS and SIRS following initial resuscitation and stabilisation. 
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Figure 1. Study flow diagram.  *Some studies had multiple reasons for exclusion. 
Records identified through 
database searching 
(n = 62,915) 
Additional records identified 
through other sources 
(n = 66) 
Records screened 
(n = 62,981) 
Records excluded 
(n = 62,739) 
Full-text articles assessed 
for eligibility 
(n = 242) 
Full-text articles excluded,  
(n = 193*): 
 
• Duplicate / overlap (n=60) 
• Pre-1980 (n=6) 
• Not original study (n=4) 
• Resuscitation studies (n=56) 
• Type of fluid study (n=25) 
• Complex haemodynamic 
intervention (n=12) 
• Study population did not 
match criteria(n=24) 
• Observational study with  
< 50 patients (n=24) 
• Clinical outcomes of interest 
not reported (n=4) 
• Not relevant (n=2) 
• Fluid balance not reported 
(n=10) 
 
 
 
Studies included in 
qualitative synthesis 
(n = 49) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 11) 
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Figure 2.  Risk of bias assessment for randomised trials. 
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Figure 3.  Forest plot for mortality at most protracted time point available, conservative or deresuscitative 
fluid strategy versus standard care or liberal fluid strategy. 
 
 
 17 
Figure 4. Forest plot for outcome of ventilator-free days. 
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Figure 5. Forest plot for ICU length of stay, conservative or deresuscitative fluid strategy versus standard 
care or liberal fluid strategy. 
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Author and 
publication 
year 
Methods 
and Setting 
Participants Summary of conservative or 
deresuscitative fluid strategy 
Summary of liberal fluid strategy 
or usual care 
 
Key Outcomes 
 
Mitchell et al, 
1992 
 
RCT 
 
Single 
academic 
centre in 
United 
States 
 
n=101 
 
Inclusion criteria: 
-Admitted to medical ICU 
-Pulmonary artery 
catheter inserted 
 
Exclusion criteria: 
-Technical reasons 
-Logistical reasons  
-Allergy to iodine dye 
-Pregnancy or lactation 
  
 
-Extra-Vascular Lung Water 
(EVLW)-guided strategy. 
Restriction of fluid intake when 
ELVW ≥ 7 ml/kg and diuresis if 
stable. 
 
-Mean fluid balance was 142 +/- 
3632 ml at 60 hours* 
 
-Mean daily fluid balance over 
study period: 0.8 ml/kg/day 
 
-Pulmonary capillary wedge 
pressure (PCWP) – guided 
strategy with target range of 10-
17 mmHg. 
 
 
-Mean fluid balance was 2239 
+/-3695 ml at 47 hours* 
 
-Mean daily fluid balance over 
study period: 16.3 ml/kg/day 
 
-ICU mortality 
-Hospital mortality 
-Duration of 
mechanical 
ventilation 
-Length of ICU stay 
 
 
Martin et al, 
2002 
 
RCT 
 
Two 
academic 
centres in 
United 
States 
 
n=37 
 
Inclusion criteria: 
-ARDS 
-Serum total protein ≤ 
5g/dL 
-Ongoing nutritional 
support 
-Mechanical ventilation ≥ 
48 hours 
 
Exclusion criteria: 
-Haemodynamic instability 
-Renal disease 
-Hepatic failure or 
cirrhosis 
-Age <8 or >80 years 
-Pregnancy 
-Serum sodium >150 
mmol/L or potassium <2.5 
mmol/L 
 
-Furosemide infusion titrated to 
weight loss of ≥ 1 kg/day, and 
25g IV albumin 8 hourly for 5 
days 
 
-Mean weight loss of 10.0 kg 
after 5 days* 
 
-Mean daily fluid balance over 
study period: -47.6 ml/kg/day 
 
-Dual placebo 
 
 
 
 
-Mean weight loss of 4.7 kg after 
5 days* 
 
-Mean daily fluid balance over 
study period: -22.4 ml/kg/day 
 
-30 day mortality 
-ICU-free days 
-Ventilator-free days 
-Length of hospital 
stay 
 
 
Martin et al, 
 
RCT 
 
n=40 
 
-Furosemide 20mg IV bolus 
 
-Furosemide 20mg IV bolus 
 
-30 day mortality 
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2005  
Two 
academic 
centres in 
United 
States 
 
Inclusion criteria: 
-ARDS 
-Serum total protein < 6 
g/dL 
 
Exclusion criteria: 
-Haemodynamic instability 
-Renal disease or 
cirrhosis 
-Age < 18 years 
-Pregnancy 
-Serum sodium > 155 
mmol/L or potassium < 
2.5 mmol/L 
followed by infusion, and 25g IV 
albumin 8 hourly for 3 days 
 
-Mean net fluid balance after 3 
days was -5480 ml* 
 
-Mean daily fluid balance over 
study period: -15.7 ml/kg/day 
followed by infusion, with 0.9% 
saline placebo for 3 days. 
 
-Mean net fluid balance at 3 
days was -1490 ml* 
 
-Mean daily fluid balance over 
study period: -4.3 ml/kg/day 
-Ventilator-free days 
-Change in SOFA 
scores 
 
Wiedemann et 
al, 2006 
 
RCT 
 
Multiple 
community 
and 
academic 
ICUs in 
United 
States and 
Canada 
 
n=1000 
 
Inclusion criteria: 
-ARDS 
-Intubated and 
mechanically ventilated 
-Presence or intention to 
insert a central venous 
catheter 
 
Exclusion criteria: 
-Presence of ALI/ARDS 
for > 48 hours 
-Severe chronic illness 
likely to independently 
influence survival  
-Irreversible terminal 
illness 
 
-Complex algorithm with fluid 
boluses or diuretics 
administered as directed by 
filling pressures (CVP or 
PCWP). 
 
 
-41% of protocol instructions 
involved administration of 
furosemide, 6% involved fluid 
boluses 
 
-At 7 days, net fluid balance was 
-136 ml +/- 11012 ml* 
 
-Mean daily fluid balance over 
study period: -0.3 ml/kg/day 
 
-Complex algorithm with fluid 
boluses or diuretics 
administered as directed to 
target higher filling pressures 
(CVP or PCWP) than in 
conservative group. 
 
-10% of protocol instructions 
involved administration of 
furosemide, 15% involved fluid 
boluses 
 
-At 7 days, net fluid balance was 
6992 ml +/- 11191 ml* 
 
-Mean daily fluid balance over 
study period: 14.3 ml/kg/day 
 
 
-60-day mortality 
-Ventilator-free days 
-ICU-free days 
-Renal failure-free 
days 
-RRT use 
-CNS failure-free 
days 
 
 
Hu et al, 2014 
 
RCT 
 
Single 
centre in 
China 
 
n=29 
 
Inclusion criteria: 
-ALI/ARDS (AECC 
criteria) 
-Admitted to ICU 
 
-Extravascular lung water target 
value set at 3-7 ml/kg, using 
diuretics or CRRT 
 
 
-Fluid administration not 
 
-Pulmonary artery occlusion 
pressure target of 8-12 mmHg, 
using diuretics or CRRT 
 
-Fluid administration not 
protocolised 
 
-60 day mortality 
-Duration of 
mechanical 
ventilation  
-Length of ICU stay 
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Exclusion criteria: 
-Pre-existing 
comorbidities including 
pulmonary hypertension, 
pneumonectomy, and 
interstitial lung disease 
protocolised 
 
-Mean fluid balance at 7 days 
was -783 ml +/- 391ml 
 
-Estiamted mean daily fluid 
balance over study period: -1.6 
ml/kg/day 
 
-Mean fluid balance at 7 days 
was -256 ml +/- 514 ml 
 
-Estimated mean daily fluid 
balance over study period: -0.5 
ml/kg/day 
 
 
Benakatti et 
al, 2014 
 
RCT 
 
Single 
centre in 
India 
 
n=101 
 
Inclusion criteria: 
-Children aged 3-144 
months 
-Septic shock following 
fluid resuscitation 
 
Exclusion criteria: 
-None reported 
 
-Maintenance fluid administered 
at 80% of calculated required 
rate 
 
-At 10 days, mean net fluid 
balance was -42.6 ml/kg +/- 82.6 
ml/kg* 
 
-Mean daily fluid balance over 
study period: -33.9 ml/kg/day 
 
 
-Regimen not clearly reported 
 
 
 
-At 10 days, net fluid balance 
was 339 ml/kg +/- 117 ml/kg* 
 
 
-Mean daily fluid balance over 
study period: -4.26 ml/kg/day  
 
-28 day mortality 
-Ventilator-free days  
-Length of ICU stay 
 
 
Wang et al, 
2014 
 
RCT 
 
Single 
centre in 
China 
 
n=100 
 
Inclusion criteria: 
-ARDS (AECC definition) 
 
Exclusion criteria: 
-Age < 13 years 
-Contraindication to 
central venous catheter 
-ARDS criteria met for > 
48 hours pre-enrollment 
-Myocardial infarction in 
last 30 days 
-History of COPD or 
neuromuscular disorder 
affecting respiration 
 
 
-Extravascular lung water index 
target of 3-7ml/kg.  Regimen 
used not clearly reported  
 
-At 7 days, mean net fluid 
balance was -9.6 ml* 
 
-Estiamted mean daily fluid 
balance over study period: -0.02 
ml/kg/day 
 
-Regimen used not clearly 
reported 
 
 
 
-At 7 days, mean net fluid 
balance was 7083.6 ml* 
 
-Estiamted mean daily fluid 
balance over study period: 14.5 
ml/kg/day 
 
-60 day mortality 
-Duration of 
mechanical 
ventilation 
-Length of ICU stay 
-Cognitive function 
domain of QLQ-C30 
quality of life score 
 
Chen and 
Kollef, 2015 
 
RCT 
 
 
n=82 
 
 
-Targeted fluid minimisation 
comprising: fluid-responsiveness 
 
-Usual care 
 
 
-Hospital mortality 
-Ventilator-free days 
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Single 
academic 
centre in 
United 
States 
Inclusion criteria: 
-Hypotension due to 
septic shock  
-Requirement for ≥ 12 
hours of vasoactive drugs 
to treat hypotension after 
fluid resuscitation ≥ 30 
ml/kg IV fluid 
 
Exclusion criteria: 
-Age <18 years 
-Pre-existing end stage 
renal disease 
-Pregnancy 
-Comfort-only goals of 
care 
testing before fluid 
administration, concentration of 
drug infusions, discontinuation 
of maintenance fluids 
 
-Diuretics and ultrafiltration not 
protocolised 
 
-At 5 days, median net fluid 
balance was 2641 ml (IQR -
1837-5075) 
 
-Estimated mean daily fluid 
balance over study period: 7.5 
ml/kg/day 
 
 
 
 
 
 
 
 
 
-At 5 days, median net fluid 
balance was 3616 ml (IQR -
1513-9746 ml) 
 
-Estiamted mean daily fluid 
balance over study period: 10.3 
ml/kg/day 
 
-RRT use 
 
 
Zhang et al, 
2015 
 
RCT 
 
Two tertiary 
centres in 
China 
 
n=350 
 
Inclusion criteria: 
-Septic shock or ARDS 
(Berlin definition) 
-<24hours since ICU 
admission 
 
Exclusion criteria: 
-Age <18 years 
- Haemorrhagic shock 
- Moribund state 
- Absence of informed 
consent 
- Contra-indication to 
catheter insertion 
- Conditions likely to 
render PiCCO 
innaccurate 
 
 
-Fluid boluses targeted to 
intrathoracic blood volume index 
(ITBVI) 850-1000 ml/m2  
 
-Identical algorithm for 
noradrenaline, dobutamine and 
nitrate use in both groups 
 
-At 7 days, mean net fluid 
balance was 3821.6 ml 
 
-Estimated mean daily fluid 
balance over study period: 7.8 
ml/kg/day 
 
-Fluid boluses targeted to CVP 
8-12 mmHg. 
 
 
-Identical algorithm for 
noradrenaline, dobutamine and 
nitrate use in both groups 
 
-At 7 days, mean net fluid 
balance was 3974.5 ml 
 
-Estimated mean daily fluid 
balance over study period: 8.1 
ml/kg/day 
 
-28 day mortality 
-Ventilator-free days 
-ICU length of stay 
-Maximum SOFA 
score  
-RRT-free days 
 
 
Richard et al, 
2015 
 
RCT 
 
 
N=60 
 
 
-Fluid boluses targeted to pulse 
pressure variation < 13% (if 
 
-Fluid boluses targeted to CVP 
≥8 mmHg for duration of shock 
 
-28 day mortality 
-Ventilator-free days 
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Single 
centre in 
France 
Inclusion criteria: 
-Age ≥ 18 years 
-Septic shock 
-Pre-enrollment fluid 
loading ≥ 25 ml/kg body 
weight 
-Onset of hypotension 
<12 hours pre-enrollment 
 
Exclusion criteria: 
-Pregnancy 
-Acute coronary 
syndrome or cardiogenic 
pulmonary oedema 
-Acute cerebral event <30 
days 
-Cannulation 
contraindicated  
-Uncontrolled 
haemorrhage, need for 
immediate surgery 
-Trauma or burns > 20% 
BSA 
-Previous inclusion in 
RCT 
-Limitation of treatment 
-Absence of consent, 
legal protection order or 
lack of social security 
 
criteria for PPV use met) and Δ 
stroke volume <10% in 
response to passive leg raise 
manoeuver for duration of shock 
 
-Identical protocol for use of 
noradrenaline, dobutamine, and 
red blood cells 
 
-Median daily fluid balance for 
duration of shock was 888 ml 
(IQR 153 to 2816 ml)* 
 
-Estimated mean daily fluid 
balance over study period: 2.6 
ml/kg/day 
 
 
 
 
 
- Identical protocol for use of 
noradrenaline, dobutamine, and 
red blood cells 
 
-Median daily fluid balance for 
duration of shock was 1749 ml 
(IQR 146 to 2788 ml)* 
 
-Estimated mean daily fluid 
balance over study period: 3.2 
ml/kg/day 
-Length of ICU stay 
(survivors) 
-Number of days with 
SOFA ≥ 6 
 
Hjortrup et al, 
2016 
 
 
RCT 
 
Nine 
centres in 
Denmark 
and Finland 
 
 
N=151 
 
Inclusion criteria: 
-Age ≥ 18 years 
-Treated in ICU 
-Sepsis with circulatory 
impairment  
-Fluid bolus administration 
≥ 30 ml/kg ideal body 
weight 
 
-Noradrenaline used to maintain 
mean arterial pressure ≥ 65 
mmHg or appropriate target 
 
-250 to 500 ml crystalloid 
boluses could be administered 
only if evidence of 
hypoperfusion (lactate ≥ 4 
mmol/L, mean arterial pressure 
<50mmHg, skin mottling beyond 
 
-Noradrenaline used to maintain 
mean arterial pressure ≥ 65 
mmHg or appropriate target 
 
-Crystalloid boluses could be 
administered provided evidence 
of fluid responsiveness present 
according to static or dynamic 
variables of clinician’s choice 
 
 
-90 day mortality 
-Ventilator-free days 
-Length of ICU stay 
-RRT use 
-Worsening AKI 
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-Noradrenaline infusion 
used to mainatin blood 
pressure 
 
Exclusion criteria: 
-Receiving RRT (or 
deemed imminent) 
-Plasma potassium > 6 
mmol/L within last 6 hours 
-Creatinine level > 350 
μmol/L 
-FiO2 > 0.8 and positive 
end expiratory pressure > 
10 cmH2O 
-Life-threatening bleeding 
-Burns > 10% BSA 
-Lack of commitment to 
full life support 
-Consent unobtainable 
-Kidney or liver transplant 
during same admission 
-Previous enrollment in 
this trial 
 
edge of kneecap, urine output ≤ 
0.1 ml/kg ideal body weight 
within 2 hours of randomisation) 
 
-At 5 days, median fluid balance 
was 1752 ml (IQR 407 to 5114 
ml) 
 
-Estimated mean daily fluid 
balance over study period: 5.4 
ml/kg/day 
 
 
 
 
-At 5 days, median fluid balance 
was 2680 ml (IQR -1153 to 3758 
ml) 
 
-Estimated mean daily fluid 
balance over study period: 9.1 
ml/kg/day 
 
 
 
Table 1.  Characteristics of included randomised trials.  Unless otherwise specified, standard definitions are used for ALI, ARDS, SIRS, sepsis and septic 
shock.  [70-72].  *Denotes studies in which between-group differences in fluid balance was considered to be clinically-significant.  Unless otherwise specified, 
data are presented as mean +/- standard deviation.  RCT: Randomised controlled trial; EVLW: Extravascular lung water; PCWP: Pulmonary capillary wedge 
pressure; Ml: Millilitres; IV: intravenous; SOFA: Sequential organ failure assessment; CVP: Central venous pressure; ALI: Acute lung injury; AECC: 
American-European Consensus Conference; CRRT: continuous renal replacement therapy; PiCCO: Pulse Index Continuous Cardiac Output; QLQ-C30: 
Quality of life questionnaire core-30; COPD: Chronic obstructive pulmonary disease; ITBVI: Intrathoracic blood volume index; IQR: Interquartile range; PPV: 
Pulse pressure variation; BSA: Body surface area; FiO2: Fraction of Inspired Oxygen. 
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Quality assessment 
 
№ of patients 
 
Effect 
 
Quality 
 
Importance 
 
№ of 
studies 
Study 
design Risk of bias Inconsistency Indirectness Imprecision 
Other 
considerations 
Conservative or 
deresuscitative 
fluid strategy 
Liberal fluid 
strategy or 
usual care 
Relative 
(95% CI) 
Absolute 
(95% CI)   
Mortality 
 
11  randomised 
trials  
serious 1 not serious  very serious 2 serious  none  337/973 (34.6%)  373/977 
(38.2%)  
RR 0.92 
(0.82 to 1.03)  
31 fewer per 
1,000 
(from 11 more to 
69 fewer)  
⨁◯◯◯ 
VERY 
LOW  
CRITICAL  
Ventilator free days 
 
7  randomised 
trials  
not serious  not serious  very serious 2 not serious  none  891  893  -  MD 1.82 days 
more 
(0.53 more to 3.1 
more)  
⨁⨁◯◯ 
LOW  
IMPORTANT  
Intensive Care Unit (ICU) length of stay 
 
7  randomised 
trials  
serious 3 serious 4 very serious 2 not serious  none  444  448  -  MD 1.88 days 
fewer 
(0.12 fewer to 
3.64 fewer)  
⨁◯◯◯ 
VERY 
LOW  
IMPORTANT  
Renal Replacement Therapy (RRT) use 
 
3  randomised 
trials  
not serious  not serious  very serious 2 serious 5 none  83/619 (13.4%)  100/614 
(16.3%)  
RR 0.88 
(0.64 to 1.22)  
20 fewer per 
1,000 
(from 36 more to 
59 fewer)  
⨁◯◯◯ 
VERY 
LOW  
CRITICAL  
Post-ICU Cognitive function (assessed with: QLQ-C30 congitive function domain; Scale from: 0 to 100, with higher scores denoting better cognitive function) 
 
1  randomised 
trials  
very serious 6 not serious  serious 7 serious 5 none  50  50  -  MD 10.71 Points 
higher 
(5.22 higher to 
16.2 higher)  
⨁◯◯
◯ 
VERY 
LOW  
CRITICAL  
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Table 2. GRADE Summary of findings table for key outcomes.  CI: Confidence interval; RR: Risk ratio; MD Mean difference.  Explanatory notes: 1.Only five studies were at 
low risk of bias, the remainder were at moderate or high risk of bias.  2. Significant variability in populations, interventions and comparators studied.  3. Only two studies were 
at low risk of bias, the remainder were at moderate or high risk of bias.  4. Considerable heterogeneity present across studies (I2=75%).  5. Insufficient number of participants 
to exclude clinically important benefit or harm.  6. Single study, uncertain risk of bias across all domains.  7. Limited available information on intervention strategy 
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Appendix 1. Summary of included observational studies.  
Author  Methods Inclusion and 
exclusion criteria 
 
Patient 
characteristics 
Key outcomes Key findings 
Abulebda et al, 
2014.  
- Secondary 
analysis of 
multicentre 
prospective 
observational 
study of genomics 
in sepsis  
 
- USA 
Inclusion: 
- Age ≤10 years 
-Septic shock 
- Enrolment in an 
ongoing genomic 
study 
 
Exclusion: 
-None reported 
N=317 
 
Non-survivors: 
-Median age 1.3 
yrs. (IQR 0.2-4.5) 
-65% male 
-Median PRISM 
score 28 (IQR 17-
37) 
 
Survivors: 
-Median age 2.9 
(IQR 1.1-6.7) 
-59% male 
-Median PRISM 
score 12 (IQR 7-
18) 
-28 day mortality 
 
- Non-survivors had a higher 
cumulative fluid balance 7 at day 7  
(median 19.5% of body weight, IQR 
10.4 to 40.1) compared to survivors 
(median 6.5% body weight, IQR -1.3 
to 14.6), p= <0.001 
 
 
 
Acheampong & 
Vincent, 2015. 
-Single centre 
prospective cohort 
study 
 
-Belgium 
 
Inclusion: 
->15yrs of age 
-Admitted during 
2012 
-Suspected or 
proven infection 
treated with 
antibiotics 
-Sepsis-
associated organ 
failure by SOFA 
subscore 3 or 4 
-ICU stay >48h 
 
Exclusion: 
-None reported 
N=173 
 
-Age 61yrs +/- 16 
-68% male 
-SOFA score 8.2 
+/- 3.4 
-78% septic shock 
-60% medical, 
17% elective 
surgery, 23% 
emergency 
surgery 
 
-ICU mortality -Daily fluid balance was greater in 
non-survivors than survivors (29 ± 
22 vs. 13 ± 19 ml/kg, p  <0.001).  
 
-Positive fluid balance was 
independently associated with higher 
mortality (adjusted hazard ratio 
1.014 per ml/kg, P<0.001) 
 
-Diuretics were used in 41% of non-
survivors, 29% of survivors 
 
Bhaskar et al, -Retrospective Inclusion: N=114 -ICU mortality -Independent risk factors for 
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2015. cohort study 
 
- USA 
- Shock states 
(majority sepsis or 
SIRS) 
- Age ≤ 18 years 
 
Exclusion: 
- PICU length of 
stay < 48 hours 
-Premature 
neonates 
-Post-operative 
congenital heart 
disease 
 
 
-Median age 1.1 
yrs. (Range 0-
17.4) 
-59% male 
-Median Paediatric 
Index of Mortality 
2 score 5.1 
(Range 0.2-99.3) 
-Sepsis or septic 
shock 83% 
 
-Duration of 
mechanical 
ventilation 
(survivors) 
-Renal 
replacement 
therapy use 
-Length of ICU 
stay 
mortality included 
presence of fluid overload (≥10% 
body weight at 3 days) (adjusted OR 
9.17, 95% CI 2.22-55.57); peak fluid 
overload within 7 days (adjusted OR 
1.13 per % body weight, 95% CI 
1.07-1.23); and duration of fluid 
overload (adjusted OR 1.61 per day, 
95% CI 1.21-2.28) 
 
- Compared with matched controls, 
cases with fluid overload ≥10% body 
weight at 3 days, had higher 
mortality (37% versus 3%, P=0.002); 
similar duration of mechanical 
ventilation (median 6 days versus 5 
days, P=0.36), similar rates of RRT 
use (37% vs 13%, P=0.07) and 
similar length of ICU stay (median 9 
days versus 8 days, P=0.73). 
 
Bihari et al, 2013. 
 
-Single centre 
prospective 
observational 
study investigating 
the prevalence 
and efficacy of 
fluid boluses after 
initial resuscitation 
in septic patients. 
 
-Tertiary centre in 
Australia 
 
Inclusion: 
-Age > 18 years 
- Severe sepsis or 
septic shock  
-Within 2 hours of 
completing initial 6 
hours  of 
resuscitation 
 
Exclusion: 
-Expectation of 
death within 24 
hours 
- Patients not 
undergoing active 
treatment 
-Patients with 
clinically obvious 
ongoing 
N=50 
 
-Median age 72.5 
yrs. (61.0-82.8) 
-66% male (33) 
-Median APACHE 
3 score 80 (IQR 
68-93) 
-Median SOFA 
score 9 (IQR 6-11) 
-26% mechanically 
ventilated 
 
- Change (Δ) in 
SOFA score 
-Cumulative fluid balance was 
weakly correlated with Δ SOFA 
score at 48 and 72 hours (r=0.32, 
P=0.001) 
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haemorrhage, GI 
or other fluid loss 
- Pregnancy 
 
Botdorf et al, 
2015. 
- Single centre 
retrospective 
cohort study 
 
- USA 
Inclusion: 
-Suspected sepsis 
-ICU stay > 24hrs 
 
Exclusion: 
- None reported 
N=162 
 
-Median age 68 
yrs. (IQR 58-79) 
-55% male 
-Median APACHE 
4 score 83 (IQR 
67-104) 
-ICU mortality - Net fluid balance at 48 hours was 
higher in non-survivors compared to 
survivors (median 8790 ml, IQR 
4530 to 11400 vs median 5380 ml, 
IQR 2900 to 7820, p=0.023) 
 
Boyd et al, 2011. -Secondary 
analysis of a 
multicentre 
randomised 
controlled trial of 
vasopressin 
versus 
norepinephrine in 
27 centres in 
Canada, Australia 
and USA 
Inclusion: 
-Septic shock 
-Minimum of 
5mcg/min 
noradrenaline 
infusion 
 
Exclusion: 
- Unstable 
coronary 
syndrome 
->24 hours since 
enrolment criteria 
met 
-Estimated 6 
month mortality 
>50% 
-Suspected or 
proven mesenteric 
ischaemia 
-Underlying 
chronic heart 
disease 
-Anticipation of 
imminent death or 
lack of 
commitment to 
aggressive care 
N=778 
 
Not reported for 
overall cohort 
- 28-day mortality - Higher net fluid balance at 4 days 
(and at 12 hours) was an 
independent risk factor for mortality: 
adjusted hazard ratios by quartiles 
with decreasing fluid balances 0.739 
(95% CI 0.503-1.087), 0.512 (0.339-
0.775), 0.466 (0.299 – 0.724). 
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Chen et al, 2011. 
 
-Single centre 
retrospective 
cohort study 
 
-China 
Inclusion: 
-Septic shock 
(ACP/SCCM 
criteria) 
 
Exclusion: 
-Fluid bolus or 
vasopressor 
administration in 
another hospital 
N=107 
 
Survivors (n=68): 
-Age 66.7 years 
+/- 14.5 
-78% male 
-APACHE score 
14.7 +/-3.1 
-SOFA score 6.5 
+/- 1.5 
 
Non-survivors 
(n=39) 
-Age 68.88 +/- 
13.1 years 
-69% male 
-APACHE score 
16.3 +/- 3.6 
-SOFA score 7.2 
+/- 1.5 
-28 day mortality 
 
-Absence of conservative late fluid 
management, negative fluid balance 
in first week < 2 litres, and total 
intake in first week > 20 litres were 
independent risk factors for mortality. 
Cordemans et al, 
2012. 
-Retrospective 
observational 
cohort study 
comparing an 
intervention group 
who received PAL 
treatment (PEEP, 
hyperoncotic 
albumin boluses, 
and furosemide or 
CRRT to target 
neutral to negative 
fluid balance with 
a control group. 
 
-2 academic ICUs 
(1 centre) 
 
-Belgium 
Inclusion: 
-Intubated and 
mechanically 
ventilated 
-ALI 
-Transpulmonary 
thermodilution 
catheter monitored 
 
Exclusion: 
- None reported 
N=114 
 
Control Group 
(n=57): 
-Age 61.4 +/- 16.8 
-73.7% male 
-Medical ICU 
87.7% 
-SAPS II 52.3 +/- 
17.3 
-APACHE II 22.7 
+/- 11.1 
 
Treatment Group 
(n=57): 
-Age 63.0 +/- 14.3 
-66.7% male 
-Medical ICU 
91.2% 
-28-day mortality 
-ICU length of stay 
-Hospital length of 
stay 
-Duration of 
mechanical 
ventilation 
 
- Cumulative fluid balance in PAL 
treatment group -1451 +/- 1761ml at 
1 week versus 8027 +/- 1451ml in 
control group. 
 
-28 day mortality was lower in the 
PAL-treated group (28.1% vs 49.1%, 
P=0.034) 
 
-ICU length of stay was shorter in 
the PAL-treated group (23.6+/- 15 
days vs 38.1 +/- 19.9 days, p = 
0.006) 
 
-No difference in Hospital length of 
stay (69.8 +/- 66.9 days in PAL-
treated vs 82.5 +/- 57.6) 
 
-Duration of mechanical ventilation 
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 -SAPS II 47.9 +/- 
18.4 
-APACHE II 22.9 
+/- 11.4 
 
was significantly shorter in the PAL 
treated group (14.6 +/- 10.7 days vs 
25.5 +/- 20.2, p = 0.02) 
 
Cronhjort et al, 
2016.   
- Secondary 
analysis of a 
multicentre RCT of 
transfusion 
strategies in septic 
shock 
 
- Denmark, 
Norway, Sweden 
and Finland 
Inclusion: 
- Adults with septic 
shock 
- Haemoglobin 
level < 90g/dL 
- ICU stay  ≥ 3 
days 
 
Exclusion: 
-Receipt of blood 
transfusion pre-
enrollment 
-Life-threatening 
bleeding 
- Active 
myocardial 
ischaemia 
 
N=841 
 
Quartile 1 (Lowest 
fluid balance): 
- Age 63 +/-14 
- 56.8% male 
- SOFA score 10.2 
+/- 3.1 
 
Quartile 2: 
- Age 66 +/- 12 
- 59% male 
- SOFA score 9.7 
+/- 3.1 
 
Quartile 3: 
- Age 65 +/- 13 
- 50.6% male 
- SOFA score 10.1 
+/- 3.5 
 
Quartile 4 (Highest 
fluid balance): 
- Age 65 +/- 12 
- 51.6% male 
- SOFA score 10.2 
+/- 3.4 
- 90 day mortality 
 
- RRT-free days 
(% of 90 days) 
 
- VFDs (% of 90 
days) 
 
- Days alive and 
out of hospital (% 
of 90 days) 
- Fluid balance (by quartiles) was not 
associated with 90-day mortality in 
multivariate analysis (Q2 HR 1.11 
(95% CI 0.83-1.50, Q3 HR 1.19, 
95% CI 0.90-1.56, Q4 HR 1.30, 95% 
CI 0.97-1.75) 
 
- A more positive fluid balance was 
associated with similar number of 
days on RRT (Q1 82%, Q2 85% Q3 
87% Q4 81%, P=0.27) 
 
- A more positive fluid balance was 
associated with fewer VFDs (Q1 – 
72%, Q2 68%, Q3 67%, Q4 58%, 
P=0.01) 
 
- A more positive fluid balance was 
associated with fewer days alive and 
out of hospital (Q1 36%, Q2 30%, 
Q3 30%, Q4 23%, P<0.001) 
 
 
 
 
 
 
 
De Oliveira et al, 
2015. 
-Retrospective 
analysis of a 
single centre 
prospective cohort 
study in an tertiary 
centre in Brazil 
 
Inclusion: 
-Age > 18 years 
-Severe sepsis or 
septic shock 
 
Exclusion: 
-Pregnancy 
N=116 
 
- Median age 60 
yrs. (IQR 44-74) 
- 63.5% male 
- Median APACHE 
2 score 17 (IQR 
- Hospital mortality  
- Acute kidney 
injury (RIFLE-F) 
- No difference in fluid balance at 6 
hours, 12 hours or 24 hours between 
survivors and non-survivors 
 
-Fluid balance at 24-48 hours > 
3000ml was an independent risk 
factor for mortality (adjusted OR 
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-Expectation of 
death within 24 
hours 
23-26) 
 
3.19, 95% CI 1.19-8.54, p=0.021) 
-  
-Fluid balance was not associated 
with AKI 
 
Fiorenza & Pass, 
2013. 
-Single centre 
retrospective 
cohort study 
-USA 
Inclusion: 
-severe sepsis or 
septic shock in 
critical care unit 
- CVC in situ and 
CVP measured 
 
Exclusion: 
-None reported 
 
N=78 
 
Patient 
characteristics not 
reported 
28-day mortality - Non-survivors had a more positive 
fluid balance than survivors on days 
1-3 (Day 1: 4071 mL vs. 1640 mL, 
respectively; p = 0.002; Day 2: 3473 
mL vs. 1082 mL, p = 0.029; Day 3: 
1090 mL vs. 59 mL, p = 0.004). 
Flori et al, 2011. -Post-hoc analysis 
of a prospective 
observational 
study in 2 centres 
 
-USA 
Inclusion: 
-Children admitted 
to participating 
PICU during study 
period (1996-
2000)  
-ALI 
 
Exclusion: 
-<36 weeks 
corrected 
gestational age or 
>18 years 
-Evidence of left 
atrial hypertension 
clinically or by 
echo 
-
Echocardiographic 
evidence of intra-
cardiac shunt 
-Exchange 
transfusions 
-ECMO 
-CRRT 
N=320 
 
-Median age  3.4 
years (IQR 1d – 
18yrs) 
-Male 56% 
-PRISM III score 
10.3 +/- 8.7 
-PICU mortality 
 
-Ventilator-free 
days 
-Positive fluid balance was an 
independent risk factor for mortality 
(adjusted OR of 1.08 per 
10ml/kg/day, 95% CI 1.01-1.15, 
p=0.02) 
 
-More positive fluid balance (in 
10ml/kg/day increments) was 
negatively correlated with number of 
VFDs (coefficient -0.21, 95% CI -
0.39 to -0.04, p=0.02) 
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Grissom et al, 
2015. 
-Retrospective 
analysis of data 
from  4 large 
RCTs 
 
-Multicentre data, 
mainly from USA 
 
- 3-way 
comparison of 
outcomes using 
comparing a 
simplified 
conservative fluid 
management 
protocol (FACTT 
Lite) with 
conservative and 
liberal fluid 
regimens from 
FACTT trial [15] 
 
 
Inclusion: 
-Enrolment in one 
of 4 randomised 
trials in ARDS – 
FACTT, EDEN, 
OMEGA and 
ALTA. 
- presence of CVC 
 
Exclusion: 
-Chronic dialysis 
dependence 
 
N=2124 
 
FACTT Lite group: 
-Age 51.5 yrs. +/- 
0.5  
-Male 52% 
-APACHE 3 score 
91.0 +/-0.8 
 
FACTT 
conservative: 
-Age 50.1 yrs. +/- 
0.7 
-Male 52% 
-APACHE 3 score 
93.1 +/- 1.4 
 
FACTT liberal: 
-Age 49.5 yrs. +/- 
0.7 
-55% male 
-APACHE 3 score 
95.2 +/- 1.4 
 
 
- 60 day mortality 
- Ventilator free 
days 
-ICU-free days 
-Acute kidney 
injury (increase in 
serum creatinine 
by ≥ 0.3 mg/dl or 
by ≥ 50%) 
-Fluid balance at 7 days in the 
FACCT lite group was intermediate 
between the two arms of the FACCT 
trial [15] (1918 +/-323 ml versus -136 
+/- 491 ml and 6992 +/-502ml). 
 
- 60-day mortality was similar in all 3 
cohorts (FACTT Lite vs FACTT 
Liberal p=0.56, FACTT Lite vs 
FACTT Conservative p=0.91) after 
adjustment for age and severity of 
illness 
 
-The number of ventilator free days 
was similar between FACCT Lite 
and FACTT conservative groups, but 
there were more in FACTT Lite 
compared to FACTT Liberal (14.9+/-
0.3 vs 12.1 +/-0.5 days, P<0.001). 
 
-The number of ICU free days was 
similar between FACCT Lite and 
FACTT Conservative, but there were 
more in FACTT Lite compared to 
FACTT Liberal (14.4 +/-0.3 vs 11.2 
+/-0.4, P<0.001) 
 
- Acute kidney injury rates (adjusted 
for fluid balance) were similar 
between FACCT Lite and FACTT 
Conservative groups, but were lower 
in FACTT Lite compared to FACTT 
Liberal (56% vs 66%, p=<0.001) 
 
Herrera Gutierrez 
et al, 2013. 
-Single centre 
prospective cohort 
study 
 
-Spain 
Inclusion: 
-Sepsis 
(undefined) 
 
Exclusion: 
-Unclear 
N=129 
 
-Age 56.8yrs +/- 
16.7  
-58.8% male 
-APACHE 2 score 
-28 day mortality 
 
-Acute kidney 
injury (KDIGO) 
during ICU stay 
-Increasing severity of AKI was 
associated with more positive fluid 
balance (as percentage of body 
weight) at day 3: 0.23% +/- 6.3 
(KDIGO Stage 0), 6.65% +/- 2.15 
(KDIGO Stage 1, P=0.08), 6.95% +/- 
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23.9 +/- 7.7 at 
admission 
-SOFA score 12.2 
+/- 5.1 at 
admission 
1.67 (KDIGO Stage 2, P=0.08), 
7.87% +/- 6.29 (KDIGO Stage 3, 
P<0.001) 
 
-Day 3 net fluid balance (as % of 
total body weight) was significantly 
lower in survivors than non-survivors 
(0.7% +/- 6.4 vs 6.7% +/-6.6, 
P<0.0001) 
 
-Day 3 net fluid balance was an 
independent risk factor for mortality 
(adjusted OR 1.13, 95% CI 1.06-
1.22) 
Kongsayreepong 
& Nitikaroon, 
2013. 
-Prospective 
single centre 
cohort study 
 
-Thailand 
Inclusion: 
- Post noncardiac 
surgery 
- Age ≥ 18 years 
-Severe sepsis or 
septic shock 
 
Exclusion: 
-None reported 
 
N=196 
 
Patient 
characteristics not 
reported 
-Acute kidney 
injury (Acute 
Kidney Injury 
Network score ≥ 
stage 1) 
-Fluid overload was not an 
independent risk factor for AKI. 
Koonrangsesomboo
n & Khwannimit, 
2015. 
-Single centre 
retrospective 
cohort study 
 
-Thailand 
Inclusion: 
- Septic shock 
requring ICU 
 
Exclusion: 
- ICU length of 
stay < 24 hours 
N=1048 
 
- Median age 59 
(IQR 44.75 – 73) 
- 58.3% Male 
- Median APACHE 
II score 27 (21-
34.5) 
-Median SOFA 
score 10 (IQR 8-
13) 
 
 
- ICU mortality 
 
- Hospital mortality 
- After grouping based on 72-hour 
fluid balance quartiles, the 3rd and 4th 
quartiles were independently 
associated with ICU mortality 
(adjusted OR 3.04 [95% CI 1.90-
4.84] and 4.16 [95% CI 2.49-6.95] 
per litre respectively. 
 
- After grouping based on 72-hour 
fluid balance, the 3rd and 4th quartiles 
were independently associated with 
hospital mortality (adjusted OR 2.75 
[95% CI 1.74-4.36] and 3.16 [95% CI 
1.87-5.35] per litre respectively. 
 
Micek et al, 2013. - Single centre Inclusion: N=325 - Hospital mortality - Non-survivors had a more positive 
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retrospective 
cohort study 
 
- USA 
-Septic shock 
-Transthoracic 
echocardiogram 
performed within 
24 hours of onset 
of shock 
 
Exclusion: 
-Pre-existing non-
sepsis related 
cardiovascular 
compromise 
-ECMO or VAD 
use 
- Shock onset at 
outside hospital 
prior to transfer 
 
Survivors: 
-Age 58.5 yrs. +/- 
14.6 
- Male 46.3% 
-APACHE 2 score 
21.7 +/- 6.3 
 
Non-survivors: 
-Age 63.0 yrs. +/- 
14.0 
-male 44.8% 
-APACHE 2 score 
25.1 +/- 6.7 
 
fluid balance in the 8 days following 
shock onset (median 7742 ml [2914-
15992] versus 3286.5 ml [1508.5 – 
7467], P<0.001) 
 
- The quartile with the highest fluid 
balance had significantly higher 
mortality risk (P<0.001 compared to 
the lowest fluid balance quartile) 
 
-Being in the highest fluid balance 
quartile was an independent risk 
factor for death (adjusted OR 1.66 
[1.39-1.98], P=0.004) 
 
Murai et al, 2014. - Multicentre 
retrospective 
cohort study 
 
- Japan 
Inclusion: 
- ARDS 
- Mechanical 
ventilation 
- Transpulmonary 
thermodilution 
monitoring used 
 
Exclusion: 
- None reported 
 
N=207 
 
Patient 
characteristics not 
reported 
- 28 day mortality 
 
 
- Fluid balance after 3 days was 
higher in non-survivors than 
survivors, both before (5.1 +/- 4.3 L 
vs 3.5 +/- 0.4 L, P=0.03) and after 
exclusion of patients with SOFA-CV 
or SOFA-renal score >2 (3.8 +/- 1.6 
L vs 2.2 +/- 4.0 L, P=0.03). 
 
- Fluid balance after 3 days was an 
independent predictor of 28 day 
mortality (adjusted OR 1.0001, 95% 
CI 1.000017 – 1.00022, P=0.03) 
 
Murphy et al, 
2009. 
-Retrospective 
cohort study 
 
- 2 academic 
centres in USA 
Inclusion: 
-Septic shock  
- ALI (AECC 
definition) 
-Mechanical 
ventilation > 24 
hrs. 
 
Exclusion: 
-Hospitalisation for 
N=212 
 
Survivors: 
- Age 58.5yrs +/- 
15.8 
- 62% male 
- APACHE 2 score 
23.9 +/- 6.0 
- SOFA score 9.5 
+/- 2.5 
- Hospital mortality 
 
-Net fluid balance after 7 days was 
higher in non-survivors than 
survivors (median 13,694 ml; IQR 
7113-20249 vs 8062 ml; IQR 2412-
13833, p < 0.001). 
 
-Absence of ‘conservative late fluid 
management’ (defined as even to 
negative fluid balance on ≥ 2 
consecutive days) was an 
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> 7 days following 
septic shock onset 
- Reason for 
cardiovascular 
compromise other 
than septic shock 
- ECMO or VAD 
use 
- Onset of septic 
shock while at 
non-participating 
hospital 
 
Non-survivors: 
-Age 60.7yrs +/- 
14.9  
-47% male 
-APACHE 2 score 
26.7 +/- 7.3 
- SOFA score 11.0 
+/- 3.3 
 
independent risk factor for hospital 
mortality (adjusted OR 6.13, 95% CI 
2.77-13.57, P<0.001) 
 
-Absence of ‘adequate initial fluid 
resuscitation’ (defined as ≥ 20 ml/kg 
fluid bolus before administration of 
vasopressors and CVP ≥ 8 mmHg 
within 6 hours of shock onset) was 
also an independent risk factor for 
mortality (adjusted OR 4.94, 95% CI 
2.07-11.79, P<0.001) 
 
Perez-Fernandez  
et al, 2011. 
-Prospective 
single centre 
cohort study 
 
-Spain 
Inclusion: 
-Septic shock 
-Acute renal failure 
on CRRT for >24 
hours 
 
Exclusion: 
- None reported 
N=262 
 
-Age 62yrs +/- 13  
-69.8% male 
-APACHE 2 score 
26 +/- 8 
-SOFA score 12 
+/- 3.8 
- 57% medical, 
43% surgical 
-87.9% 
mechanically 
ventilated 
 
-90-day mortality 
 
-Mortality higher in positive balance 
group (> +ve 1000ml/initial 24hr on 
initial 24 hours of CRRT) compared 
with “isovolaemic” group (< +ve 
1000ml/initial 24hr on CRRT) (70.8% 
vs 55%). 
 
-Positive fluid balance over 24hrs on 
CRRT was an independent risk 
factor for 90 day mortality (p < 
0.0001) 
 
Raimundo et al, 
2012. 
-Single centre 
retrospective 
cohort study 
 
-Portugal 
Inclusion: 
-All patients 
admitted to ICU 
over 1 year due to 
sepsis 
 
Exclusion: 
- ICU stay <24 
hours 
N=68 
 
-Age 63.4 yrs. +/- 
16.2  
-73.5% male  
-APACHE 2 score 
20.1 +/- 10.3 
-SOFA score 7.1 
+/- 3.4 
-ICU mortality  
-Incidence of 
ARDS 
-ICU Length of 
stay 
-Duration of 
mechanical 
ventilation 
-Comparison between liberal 
(positive fluid balance at ICU 
discharge, n=47) and conservative 
fluid management (neutral or 
negative fluid balance at ICU 
discharge, n=21) 
 
-ICU mortality 39.7% with higher 
mortality in liberal vs conservative 
fluid balance group (55.3% vs  4.8%, 
P not reported) 
 
-ARDS more common in the liberal 
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vs conservative fluid balance group 
(25.5% vs 14.3%, P not reported) 
 
-No significant difference in ICU 
length of stay between groups (10.7 
+/- 8.8 vs 16.5 +/- 4.9 days, P not 
reported) 
 
-No significant difference in duration 
of mechanical ventilation between 
groups (9.2 +/- 8.1 vs 10.2 +/- 8.2 
days, P not reported) 
 
Rodriguez et al, 
2013. 
-Retrospective 
single centre 
cohort study 
 
-Spain 
Inclusion: 
-Severe sepsis or 
septic shock 
 
Exclusion: 
-None reported 
N=99 
 
-Age 66.68 yrs. +/-
14 
-APACHE 2 score 
18.52 +/- 7 
-58.6% male 
 
-Mortality (time 
point undefined) 
-Duration of 
mechanical 
ventilation 
-ICU Length of 
stay 
-No significant difference in mortality 
between group with positive fluid 
balance group after 2 days and 
negative fluid balance after 2 days 
group (35.3 vs 18.6 %, p = 0.072) 
 
-Longer duration of mechanical 
ventilation in positive fluid balance 
group (9.63 ± 3.10 vs 5.59 ± 9.56, p 
< 0.05) 
 
-No significant difference in length of 
ICU stay between groups (16.96 ± 
15.38 vs 11.88 ± 12.72, p = 0.085). 
 
Rosenberg et al, 
2008. 
-Secondary 
analysis of a 
clinical trial 
comparing lung 
protective 
ventilation to 
traditional 
ventilation in 
patients with 
ARDS in 24 US 
academic 
hospitals [59] 
Inclusion: 
-ARDS or ALI 
(AECC definition) 
-Intubated and 
receiving 
mechanical 
ventilation in a 
participating 
centre 
-Fluid balance 
data available 
 
N=794 
 
Survivors: 
- Age 48yrs +/- 17 
- 59% male 
-Acute physiology 
score (APS) 70 +/- 
26 
 
Non-survivors: 
- Age 59yrs +/- 16 
- 61% male 
- Hospital mortality - Cumulative fluid balance at day 4 
was an independent risk factor for 
hospital mortality (adjusted OR 
1.034 per litre, 95% CI 1.187-1.432, 
P=0.001). 
 
- A negative fluid balance at day 4 
was associated with a lower risk of 
hospital mortality (adjusted OR 
0.502 per litre, 95% CI 0.284-0.887, 
P<0.001) 
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Exclusion: 
- >36 hours since 
inclusion criteria 
met 
- Pregnancy 
- <18 years 
- Participation in 
another clinical 
trial in <30 days 
- Physician refusal 
 
- APS 82 +/- 26 
 
Saito et al, 2012. -Retrospective 
cohort study 
evaluating 
outcomes before 
and after 
implementation of  
an ‘optimal fluid 
management’ 
strategy utilising 
PiCCO to guide 
fluid and diuretic 
use 
 
-Single centre  
-Japan 
 
Inclusion: 
-Severe sepsis or 
septic shock 
requiring 
mechanical 
ventilation 
 
Exclusion: 
- None reported 
N=96 
 
- Median age 69.5 
(IQR 55.5 – 78.5) 
- Median APACHE 
2 score 23.0 (IQR 
19-27) 
-Median SOFA 
score 10.0 (7.0-
12.0) 
-75% septic shock 
- Incidence of 
ARDS 
- Incidence of AKI 
(RIFLE-F) 
- 28 day mortality 
-OFM group (n=47) achieved a 
negative fluid balance earlier than 
the ‘before’ group (n=49) 
 
- Mortality was similar between 
groups (14.3% vs 17.0%) 
 
- Incidence of ARDS was lower in 
the ‘OFM’ group (20.4% vs 57.4%, 
P=0.02) 
 
- Incidence of AKI similar between 
groups 
 
- OFM was an independent 
protective factor for ARDS (adjusted 
OR 0.17, CI 0.06-0.51, P=0.001) 
Simmons et al, 
1987. 
- Prospective 
cohort study 
 
- Single centre 
 
- USA 
Inclusion: 
-ARDS defined as: 
-Acute respiratory 
failure with 
bilateral infiltrates 
requiring 
intubation and 
mechanical 
ventilation 
-PaO2/FiO2 ratio 
< 150mmHg within 
72 hours 
N=113 
 
-Age 54.9yrs +/- 
16.7 
-67.3% male 
-54.9% medical 
ICU 
- Hospital mortality 
 
- Overall mortality 77.9% 
- Survivors had a significantly less 
positive fluid balance and 
significantly greater weight gain over 
14 days in univariate analysis 
- By day 14, survivors were on 
average 9.72 litres less positive than 
non-survivors 
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Exclusion: 
-Pulmonary 
arterial wedge 
pressure 
>18mmHg or not 
recorded within 
24hours 
 
Smith & Perner, 
2012. 
- Prospective 
cohort study in 6 
Danish ICUs  (3 
academic, 3 
community) 
Inclusion: 
- Admission to 
participating ICU 
during study 
period  
- Septic shock 
 
Exclusion: 
- None reported 
N=164 
 
- Median age 
66yrs (IQR 59-74) 
- 57% male 
- Median SAPS II 
score 54 (IQR 46-
67) 
 
- 90-day mortality 
- RRT use 
 
- Cohort dichotomised into ‘high fluid 
intake’ (median 9.2 L, IQR 5.3-13.6 
at 72 hrs.) and ‘low fluid intake’ (2.9 
L, IQR 0.9-5.4 L at 72 hours) groups 
 
- Similar SAPS II scores, SOFA 
scores, and maximum vasopressor 
dose over 3 days  between groups 
 
- 90 day mortality was higher in the 
low fluid intake group (62% vs 40%, 
P=0.03, unadjusted comparison) 
 
- Similar rates of RRT use between 
groups (38% vs 33%, p=0.61) 
 
Spicer et al, 2014. - Multi-centre 
cohort study  
 
- USA 
 
Inclusion: 
-Children 
-ARDS 
 
Exclusion: 
-None reported 
N=209 
 
AKI cohort: 
- Age 86 months 
+/-73 
- 56% male 
- PRISM 3 score 
13 +/- 8 
 
Non-AKI cohort: 
-Age 86 months 
+/-74 
-55% male 
-PRISM 3 score 
21 +/- 11 
- Mortality (time 
point undefined) 
- Net fluid balance at day 3 was an 
independent risk factor for mortality 
in a cohort with AKI (adjusted OR 
1.89 per 100ml/kg [1.08-3.31], 
P=0.027) but not in a cohort without 
AKI 
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Sun et al, 2015. -Single centre 
retrospective 
cohort study 
 
-China 
Inclusion: 
- Age >18 years  
- Sepsis 
- AKI requiring 
RRT 
 
Exclusion: 
- Cause of AKI 
other than sepsis 
- Duration of RRT 
<72 hours 
- Incomplete 
medical records 
- Unexpected 
death within 
follow-up period 
N=117 
 
Positive fluid 
balance group: 
- Age 68.3 +/- 14.4 
- 75.5% male 
- APACHE II score 
29.6 +/- 6.2 
- SOFA score 11.1 
+/- 2.4 
 
Negative fluid 
balance group: 
- Age 67.2 +/- 16.8 
- 75.4% male 
- APACHE II score 
30.0 +/- 7.2 
- SOFA score 11.0 
+/- 2.7 
 
- 60 day mortality - Fluid overload (defined as positive 
fluid balance >10% body weight in 3 
days prior to RRT initiation) was not 
independent risk factor for 60 day 
mortality (HR 1.47, 95% CI 0.78-
2.76) 
 
- Negative fluid balance during RRT 
use (up to 7 days) was 
independently associated with lower 
risk of 60 day mortality (HR 0.44, 
95% CI 0.24-0.82) 
Udeozo et al, 
2009. 
-Retrospective 
cohort study of 
prospectively-
collected database  
 
-Single centre in 
USA 
Inclusion: 
-Septic shock 
 
Exclusion: 
-Refusal of 
consent 
-Readmissions to 
ICU 
N=390 
 
-Median age 68 
yrs. (IQR 56 – 79) 
-54% male 
-Median APACHE 
3 score 87 (IQR 
67-105) 
- Hospital mortality - Non-survivors had a lower fluid 
balance at 12 hours, but a more 
positive fluid balance in the 24-72 
hour period (median 7057 ml, 3249-
31377 vs 4196 ml, IQR 348 – 24235, 
P=0.024, unadjusted analysis) 
 
Valentine et al, 
2012. 
-Multi-centre (5 
PICUs) 
retrospective 
cohort study 
 
-USA  
Inclusion: 
-Age ≥ 1 month 
and < 18years 
-IPPV via ETT 
-ALI (AECC 
definition) 
 
Exclusion: 
-Chronic 
conditions that 
could 
N=168 
 
-Median age 3 
years (IQR 0.8 – 
11) 
-54% male 
-Median PRISM 3 
score 9 (IQR 3-13) 
-Mortality – time 
point not specified 
- Ventilator free 
days 
 
-Comparison of study cohort with 
conservative and liberal fluid groups 
from FACTT trial[15].  
 
-Secondary analysis comparing 
survivors and non-survivors in study 
cohort. 
 
- No significant differences in fluid 
balance between survivors and non-
survivors 
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independently 
impair weaning, 
especially lung or 
neuromuscular 
conditions 
-Cyanotic heart 
disease 
-Post-lung, renal 
or bone marrow 
transplant 
-Chronic renal 
failure 
-Burns > 40% BSA 
-Continuous RRT 
or ECMO 
 
- A more positive fluid balance at day 
3 was correlated with fewer VFDs 
(coefficient -0.02, p = 0.01 per ml/kg) 
 
- Total furosemide dose by day 3 
was not associated with number of 
VFDs 
Vincent et al, 
2006. (sepsis) 
 
Sakr et al, 2005 
(ARDS). 
-Prospective 
multicentre cohort 
study 
 
-198 European 
ICUs 
 
Inclusion: 
-All patients >15 
years admitted to 
participating ICU 
-Sepsis cohort: 
presence of 
infection + SIRS 
criteria 
(ACP/SCCM) 
-ALI/ARDS cohort: 
AECC criteria 
 
Exclusion: 
-Re-admission to 
ICU 
-Routine post-
operative 
admission <24 
hours 
Sepsis cohort 
(N=1177): 
-Median age 65yrs 
(IQR 51-74) 
-63% male 
-SAPS 2 score 
42.3 +/- 16.6 
-SOFA score 6.5 
+/- 4.0 
 
ALI/ARDS cohort 
(N=393): 
-Age 59 +/- 17 
-60.5% male 
-SAPS 2 score 
46.6 +/- 17.6 
-Sepsis 47.5% 
-ICU mortality 
 
Sepsis cohort: 
-Net fluid balance at 72 hours was 
an independent risk factor for ICU 
mortality (adjusted OR 1.1 per litre, 
95% CI 1.0-1.1, P<0.001) 
 
ALI/ARDS cohort: 
-Fluid balance at 72 hours was 
higher for non-survivors than 
survivors (3.6  +/- 6.4 litres vs 1.8 +/- 
5.4 litres, p=0.002) 
 
-Mean daily fluid balance was an 
independent risk factor for ICU 
mortality (adjusted OR 1.5 per litre, 
95%  CI 1.1-1.9, p = 0.003) 
 
Wang et al, 2016.  -Single centre 
retrospective 
cohort study 
 
-China 
Inclusion: 
- Septic shock 
- Age ≥ 18 years 
- Use of PiCCO 
monitoring 
- CVP target of 8-
N=105 
 
Survivors: 
- Age 66 +/- 17 
- 64.6% male 
- APACHE II score 
- 28 day mortality - Fluid balance in the 24 hour and 
24-48 hour periods post-initial 
resuscitiation both independently 
predicted 28-day mortality (adjusted 
OR 1.001 per ml, 95% CI 1.000-
1.001, P=0.016 for 24 hours; 
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12mmHg reached 
within 6 hours 
- Requirement for 
Norepinephrine ≥ 
0.1 mcg/kg/min or 
Dopamine ≥ 5 
mcg/kg/min 
- Survival time ≥ 
72 hours following 
shock onset 
 
Exclusion: 
-Pregnancy or 
breast-feeding 
- Shock in the 
absence of 
infection 
- PiCCO used for 
<48 hours or 
absent data at ≥ 2 
timepoints 
- Acute blood loss, 
acute myocardial 
infarction, 
pulmonary 
embolism 
- Treatment 
witheld or 
withdrawn during 
hopsital stay 
 
21.8 +/-7.8 
 
Non-survivors: 
- Age 65 +/- 18 
- 63.3% male 
- APACHE II score 
25.5 +/- 6.9 
adjusted OR 1.001 per ml, 95% CI 
1.000-1.002, P=0.08 for 24-48 
hours). 
Wilkowski et al, 
1988. 
-Single centre 
retrospective 
cohort study 
 
-Germany 
Inclusion: 
-ICU patients with 
ARDS, defined as 
acute respiratory 
failure after a 
typical insult, 
PaO2 < 50mmHg 
with FiO2 ≥ 0.6 
and radiological 
N=124 
 
-Age 45.4 yrs. 
(range 16-78) 
-61.3% male 
-ICU mortality -No significant difference in mortality 
between 3 treatment groups: (1) 
patients treated with diuretics (2) 
patients treated with haemofiltration 
as diuretic-unresponsive, and (3) 
patients who died or had 
spontaneous diuresis before any 
diuretics given 
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evidence of 
pulmonary 
oedema 
 
Exclusion: 
-Cardiogenic 
pulmonary 
oedema 
-COPD 
-PE 
-Pneumonia 
without pulmonary 
oedema 
 
-ICU mortality was higher in patients 
with a positive net fluid balance over 
the ICU stay (85.2% vs 66.7%, 
P<0.05) 
Willson et al, 
2015. 
 
 
-Secondary 
analysis of a large 
multi-centre 
randomised 
controlled trial 
investigating 
surfactant vs 
placebo in 
paediatric ARDS 
 
-27 sites in 6 
countries 
 
Inclusion: 
-Age <18 years 
-ALI of direct 
aetiology  
-Enrolment in 
CARDS trial 
(surfactant vs 
placebo) within 48 
hours of intubation 
 
Exclusion: 
-Indirect lung 
injury 
-Pre-existing lung 
disease 
-Limitations on 
level of support 
-Significant non-
pulmonary organ 
dysfunction 
 
N=109 
 
-Age 6.1 years  +/- 
5.8 
-51% male 
-PRISM 3 score 
11.4 (+/- 6.8) 
-Hospital mortality -Cumulative fluid balance at 7 days 
was greater in non-survivors than 
survivors (11745 ml/m2 [10817] 
versus 1234 ml/m2 [2393], P<0.001) 
Yao et al, 2014. -Single centre 
retrospective 
cohort study 
 
-China 
Inclusion: 
-Septic shock 
(ACCP/SCCM 
definition) 
 
N=105 
 
Survivors (n=77): 
-Median age 64 
yrs. (46-74) 
-Mortality (time 
point undefined) 
-Net fluid balance at day 7 which 
was positive or less negative than -
1330ml was an independent risk 
factor for mortality (adjusted OR 
2.98, P=0.037) 
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Exclusion: 
- Age<18 years 
- Pregnancy or 
lactation 
-59.7% male 
-Median APACHE 
2 score 15 (14-18) 
-Median SOFA 
score 7 (6-8) 
 
Non-survivors 
(n=28): 
-Median age 62 
yrs. (47-74) 
-53.6% male 
-Median APACHE 
2 score 19 (14-21) 
-Median SOFA 
score 9 (7-11) 
Zhang et al, 2012. -Prospective 
single-centre 
cohort study 
investigating the 
prognostic utility of 
BNP on clinically 
important  
outcomes and 
assessing 
correlation 
between fluid 
balance and 
changes in BNP 
 
-China 
Inclusion: 
-Sepsis 
-Age 18-80 years 
- PiCCO system in 
use for 
haemodynamic 
monitoring 
 
Exclusion: 
-Acute kidney 
injury (AKIN Stage 
2 or above) 
-Patients 
considered 
moribund or with 
DNAR order 
-Pre-existing renal 
dysfunction 
N=67 
 
-Age 59yrs +/- 16 
-64.2% male  
-Median APACHE 
2 score 23 (IQR 
19-31) 
-46.3% 
mechanically 
ventilated 
-Hospital mortality 
 
-Net fluid balance at day 2 was an 
independent risk factor for hospital 
mortality (OR 1.50 per 100ml, 95% 
CI 1.10 – 2.04, p = 0.01).  
 
-Change in BNP was correlated with 
change in fluid balance (Spearman’s 
rho =0.63, p < 0.01) 
 
Zhang et al, 2013. 
 
-Single centre 
retrospective 
cohort study 
 
-China 
Inclusion: 
-Sepsis induced 
AKI admitted to 
ICU 
 
Exclusion: 
-Immune 
N=160 
 
Negative fluid 
balance group: 
-Age 51.1 yrs. +/- 
18.4 
-75.3% male 
-28 day mortality 
-Length of ICU 
stay 
-Positive fluid balance (defined as no 
days of negative balance >500ml in 
first 3 days of ICU stay) was 
associated with higher mortality 
(68.4% vs 37%, p<0.01), and a 
longer ICU stay (10.1 +/- 4.9 days vs 
12.4 +/- 8.0  days, p< 0.05) 
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compromise 
-End-stage chronic 
illness 
-Age < 12 or > 80 
-Pregnancy or 
lactation 
-Learning disability 
or severe 
psychiatric illness 
-Terminal illness 
-APACHE 2 score 
17.9 +/- 6.1 
 
Positive fluid 
balance group: 
-Age 56 yrs. +/- 
18.2 
-77.2% male 
-APACHE 2 score 
18.8 +/- 5.1 
 
 
 46 
Appendix 2. Modified Newcastle-Ottawa scale for included cohort studies. 
 
Selection: 
1) Representativeness of the exposed cohort 
a) truly representative of the average ARDS / SIRS / sepsis population in the community   
b) somewhat representative of the average ARDS / SIRS / sepsis population in the community 
c) selected group of patients 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort 
a) drawn from the same community as the exposed cohort 
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records) 
b) structured interview 
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes 
b) no 
Comparability: 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for severity of illness  
b) study controls for haemodynamic status 
 
Outcome: 
1) Assessment of outcome  
a) independent blind assessment  
b) record linkage 
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes 
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for 
b) subjects lost to follow up unlikely to introduce bias > 98 % follow-up or description provided of those lost 
c) follow up rate < 99%and no description of those lost 
d) no statement 
 47 
 
Newcastle-Ottawa scores for included observational studies 
 
 Selection Comparability Outcome 
Abulebda et al, 2014. ++++ - +++ 
Acheampong & Vincent, 2015. ++++ + +++ 
Bhaskar et al, 2015.  ++++ ++ +++ 
Bihari et al, 2013. ++++ ++ ++ 
Botdorf et al, 2015. +++ - + 
Boyd et al, 2011. ++++ ++ ++ 
Chen et al, 2011. +++ + + 
Cordemans et al, 2012. ++ ++ + 
Cronhjort et al, 2016. ++++ ++ +++ 
De Oliveira et al, 2015. ++++ + ++ 
Fiorenza & Pass, 2013. +++ - + 
Flori et al, 2011. ++++ + + 
Grissom et al, 2015. +++ + +++ 
Herrera Gutierrez et al, 2013.  ++ ++ ++ 
Kongsayreepong & Nitikaroon, 2013. + ++ + 
Koonrangsesomboon & Khwannimit, 2015 ++++ + +++ 
Micek et al, 2013. ++++ + ++ 
Murai et al, 2014.  +++ - + 
Murphy et al, 2009. ++++ ++ ++ 
Perez-Fernandez et al, 2011.  +++ - + 
Raimundo et al, 2012. +++ - + 
Rodriguez et al, 2013. +++ - + 
Rosenberg et al, 2008.  ++++ ++ +++ 
Saito et al, 2012.  + + + 
Simmons et al, 1987.  +++ - ++ 
Smith & Perner, 2012.  +++ - +++ 
Spicer et al, 2014. + + + 
Sun et al, 2015.  +++ + +++ 
Udeozo et al, 2009. +++ - + 
Valentine et al, 2012. ++++ ++ + 
Vincent et al, 2006. (sepsis)  
Sakr et al , 2005. (ARDS) 
++++ 
++++ 
++ 
+ 
++ 
++ 
Wang et al, 2016. +++ + ++ 
Wilkowski et al, 1988. ++ - + 
Willson et al, 2015. +++ - +++ 
Yao et al, 2014. +++ + + 
Zhang et al, 2012. +++ ++ ++ 
Zhang et al, 2013. +++ - + 
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Appendix 3.  Additional analyses. 
 
 
 
3.1 Pre-planned sensitivity analysis excluding studies at high or moderate risk of bias with mortality as outcome. 
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3.2 Pre-planned subgroup analysis including only adult studies with mortality as outcome. 
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3.3 In a post-hoc sensitivity analysis in which we excluded studies lacking a clinically-important separation in fluid balance between groups, we found a non-
significant reduction in mortality with a conservative or deresuscitative strategy compared to a liberal strategy or standard care. 
 
We used these findings to calculate the required sample size to test the hypothesis that conservative fluid management or deresuscitation strategy reduces 
mortality compared to a liberal strategy or standard care. Based on a 13% relative risk reduction (assuming a comparable difference in mortality to those 
studies in which a clinically-significant difference in fluid balance was achieved), a baseline mortality risk of 34%, two-tailed alpha of 0.05 and power of 90%, 
we calculated this to be 4704 patients. 
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3.4 Univariate meta-regression analysis with RR for mortality as dependent variable and between-group difference in mean daily fluid balance as exposure.  
R2=0.11, P=0.30 
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3.5 Forest plot for renal replacement therapy use, conservative or deresuscitative fluid strategy versus standard care or liberal fluid strategy. 
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Appendix 5.  List of excluded studies 
 
Aboelatta and Abdelsalam.  Volume Overload of Fluid Resuscitation In Acutely Burned Patients Using 
Transpulmonary Thermodilution Technique.  Journal of Burn Care and Research 2013;34:349-354 
• Observational study with n<50 
 
Acheampong and Vincent.  Early Negative Fluid Balance Is Independently Associated With Improved 
Survival In Septic Patients.  American Journal of Respiratory and Critical Care Medicine 2014;189;A5496 
• Duplicate / overlap 
 
Acheampong and Vincent.  Early Negative Fluid Balance Is Independently Associated With Improved 
Survival In Septic Patients.  American Journal of Respiratory and Critical Care Medicine 2014;189;A5496 
• Duplicate / overlap 
 
Acheampong and Vincent.  A Positive Fluid Balance Is An Independent Prognostic Factor In Patients 
With Sepsis.  Critical Care 2015;19:251 
• Duplicate / overlap 
 
Aharoni et al.  Burn Resuscitation With A Low-Volume Plasma Regimen--Analysis of Mortality.  Burns 
1989;15:230-232 
• Fluid type study 
Almeida et al.  Impact of Positive Fluid Balance On Survival In Critically Ill Cancer Patients. Critical Care 
2010;14(S1): S524 
• Duplicate / overlap 
 
Alsous et al.  Negative Fluid Balance Predicts Survival In Patients With Septic Shock: A Retrospective 
Pilot Study.  Chest 2000;117:1749-1754 
• Observational study with n<50 
 
Andrews et al. Simplified Severe Sepsis Protocol: A Randomized Controlled Trial of Modified Early Goal-
Directed Therapy In Zambia.  Critical Care Medicine 2014;42:2315-2324 
• Complex haemodynamic intervention 
• Resuscitation phase study 
Angelo et al.  Fluid Status and Clinical Outcomes In Critically Ill Children With Sepsis: A Retrospective 
Analysis.  Critical Care Medicine 2010;38(12 S1):386 
• Duplicate / overlap 
 
Angelo et al.  Fluid Status and Clinical Outcomes In Critically Ill Children With Sepsis: A Retrospective 
Analysis.  Critical Care Medicine 2010;38(12 S1):386 
• Duplicate / overlap 
 
ARISE Investigators.  Goal-Directed Resuscitation For Patients With Early Septic Shock. The New 
England Journal of Medicine 2014;371:1496-1506 
• Resuscitation phase study 
• Complex haemodynamic intervention 
Arlati et al.  Decreased Fluid Volume To Reduce Organ Damage: A New Approach To Burn Shock 
Resuscitation? A Preliminary Study.  Resuscitation 2007;72:371-378 
• Observational study with n<50 
• Resuscitation phase study 
Azevedo et al.  Should We Need Fluid Overload In the Critically Ill Patients?  Nephrology Dialysis 
Transplantation 2013;28:I331 
• Study population did not match criteria 
Azevedo et al.  Association Between Early Fluid Balance, Organ Failures and Outcomes In Ventilated 
Patients.  Critical Care Medicine 2015;43(12 S1):170 
• Study population did not match criteria 
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Bachmann et al.  Fluid Loading During Septic Shock. Remplissage Vasculaire Dans Les Etats De Chocs 
Septiques.  Reanimation Soins Intensifs Medecine D'urgence 1989;5:334-336 
• Not original study 
Balakumar et al.  Fluid Balance Has Variable Association With Long-Term Survival In the Critically Ill.  
Critical Care Medicine 2015;43(12 S1):244 
• Study population did not match criteria 
Bataller et al.  Goal Directed Fluid Management In Resuscitated Sepsis: Evaluation of An Algorithm 
Based On Volumetric Parameters.  European Journal of Anaesthesiology 2011;28:181 
• Observational study with n<50 
 
Bayer et al.  Fluid Balance In Septic Patients Receiving Only Crystalloid Or Synthetic Fluids Plus 
Crystalloids.  Intensive Care Medicine 2010;36:0926 
• Observational study with n<50 
• Fluid type study 
Bayer et al.  Effects of Fluid Resuscitation With Synthetic Colloids Or Crystalloids Alone On Shock 
Reversal, Fluid Balance, and Patient Outcomes In Patients With Severe Sepsis: A Prospective 
Sequential Analysis. Critical Care Medicine 2012; 40:2543-2551 
• Fluid type study 
 
Benakatti et al.  Conventional Vs. Restrictive Maintenance Fluid Regime In Children With Septic Shock 
After Initial Resuscitation: A Randomized Open Label Controlled Trial.  Archives of Disease In Childhood 
2012;97:A5 
• Duplicate / overlap 
Bhaskar et al.  Early Fluid Accumulation In Children With Shock and ICU Mortality: A Matched Case-
Control Study.  Intensive Care Medicine 2015;41:8 
• Duplicate / overlap 
Bhaskar et al.  Impact of Early Fluid Overload On Mortality In Critically Ill Children - A Nested Case-
Control Study.  Critical Care Medicine 2013;41(12 S1):1000 
• Duplicate / overlap 
 
Bihari et al.  Post Resuscitation Fluid Boluses In Severe Sepsis Or Septic Shock: Prevalence and 
Efficacy (PRICE Study).  American Journal of Respiratory and Critical Care Medicine 2013;187:A3952 
• Duplicate / overlap 
 
Bocanegra et al.  A Long-Term Study of Early Fluid Therapy In Severely Burned Adults. 3. Simultaneous 
Comparison of Saline Solution Alone Or Combined With Plasma.  Jama : The Journal of The American 
Medical Association 1966;195:268-274 
• Pre-1980 
 
• Resuscitation phase study 
 
Botdorf et al.  Retrospective Analysis of Fluid Balance In The First 48 Hours of Sepsis and Outcome.  
American Journal of Respiratory and Critical Care Medicine 2015;191:A4497 
• Duplicate / overlap 
 
Boyd et al.  Over-Resuscitation With Fluid In Septic Shock Decreases Survival and Increases Time On 
The Ventilator.  American Journal of Respiratory and Critical Care Medicine 2010;181:A1137 
• Duplicate / overlap 
 
Boyd et al.  Over-Resuscitation With Fluid In Septic Shock Decreases Survival and Increases Time On 
The Ventilator.  American Journal of Respiratory and Critical Care Medicine 2010;181:A1137 
• Duplicate / overlap 
 
 55 
Carcillo et al.  Role of Early Fluid Resuscitation In Pediatric Septic Shock.  JAMA 1991;266:1242-1245 • Resuscitation phase study 
Carlsen and Perner.  Initial Fluid Resuscitation of Patients With Septic Shock In The ICU.  Acta 
Anaesthesiologica Scandinavica, Suppement 2009; 53 (119):72 
• Duplicate / overlap 
 
Carlsen et al.  Initial Fluid Resuscitation of Patients With Septic Shock In The Intensive Care Unit.  Acta 
Anaesthesiologica Scandinavica 2011;55:394-400 
• Resuscitation phase study 
 
Chang et al.  Volume of Fluids Administered During Resuscitation For Severe Sepsis and Septic Shock 
and The Development of The Acute Respiratory Distress Syndrome.  Journal of Critical Care 
2014;29:1011-1015 
• Resuscitation phase study 
 
Chen and Kollef.  Fluid Balance In The ICU-Interventions To Minimize Fluids In Patients With Septic 
Shock.  American Journal of Respiratory and Critical Care Medicine 2015;191:A5218 
• Duplicate / overlap 
 
Chen and Kollef.  Targeted Fluid Minimization Following Initial Resuscitation In Septic Shock: A Pilot 
Study.  Chest 2015; 148(6):1462-9 
• Duplicate / overlap 
 
Chen et al.  The Impact of Different Fluid Management On Mortality In Patients With Septic Shock.  
Chinese Critical Care Medicine 2011;23:142-145 
• Duplicate / overlap 
 
Cordemans et al.  Effect of Negative Fluid Balance With PAL Therapy (Peep + Albumin + Lasix) On 
Capillary Leak Index, Intra-Abdominal and Abdominal Perfusion Pressure, Extravascular Lung Water and 
Organ Function In Acute Lung Injury. Critical Care 2010:36(S2);97 
• Duplicate / overlap 
• Fluid type study 
Cordemans et al.  Effect of Negative Fluid Balance With PAL Therapy (Peep + Albumin + Lasix) On 
Capillary Leak Index, Intra-Abdominal and Abdominal Perfusion Pressure, Extravascular Lung Water and 
Organ Function In Acute Lung Injury.  Intensive Care Medicine 2010;36(S2):97 
• Duplicate / overlap 
• Fluid type study 
Cordemans et al.  Aiming For A Negative Fluid Balance In Patients With Acute Lung Injury and 
Increased Intra-Abdominal Pressure: A Pilot Study Looking At The Effects of PAL-Treatment.  Annals of 
Intensive Care 2012;2 (S1):S15 
• Duplicate / overlap 
• Fluid type study 
 
Cordemans et al.  Aiming For A Negative Fluid Balance In Patients With Acute Lung Injury and 
Increased Intraabdominal Pressure: A Pilot Study Looking At The Effects of PAL-Treatment.  Annals of 
Intensive Care 2012;2(S1):S15 
• Duplicate / overlap 
• Fluid type study 
Crowe et al.  Evaluation of A Modified Early Goal-Directed Therapy Protocol.  American Journal of 
Emergency Medicine 2010;28:689-693 
• Resuscitation phase study 
 
Cuartero et al.  Negative Fluid Balance 48 Hours After Admission Improves Survival At 28 Days In 
Critically Ill Patients. Critical Care 2012;16(S1):P241 
• Study population did not match criteria 
Cuartero et al.  Negative Fluid Balance 48 H After Admission Improves Survival At 28 Days In Critically Ill 
Patients. Critical Care 2012;16(S1):P241 
• Duplicate / overlap 
 56 
Cuartero et al.  Negative Fluid Balance 48 H After Admission Improves Survival At 28 Days In Critically Ill 
Patients.  Intensive Care Medicine 2012;38(S1):0167 
• Duplicate / overlap 
 
Cuartero et al.  Negative Fluid Balance 48 H After Admission Improves Survival At 28 Days In Critically Ill 
Patients.  Intensive Care Medicine 2012;38(S1):0167 
• Duplicate / overlap 
 
De Almeida et al.  Positive Fluid Balance Is Associated With Reduced Survival In Critically Ill Patients 
With Cancer.  Acta Anaesthesiologica Scandinavica 2012;56:712-717 
• Study population did not match criteria 
 
De Oliveira et al.  Positive Fluid Balance As A Prognostic Factor For Mortality and Acute Kidney Injury In 
Severe Sepsis and Septic Shock.  Journal of Critical Care 2015;30(1):97-101 
• Duplicate / overlap 
 
Depaye et al.   Impact of Fluid Resuscitation Volume On The Severity of Organ Failures In Severely 
Burned Patients.  Critical Care 2012;16(S1):P461 
• Resuscitation phase study 
 
Diaz-Rubia et al.  Effect of Maintained Negative Fluid Balance In Hypoxemic and High Extravascular 
Lung Water Patients. Intensive Care Medicine 2011;37(S1):0370 
• Observational study with n<50 
 
Diaz-Rubia et al.  Effect of Maintained Negative Fluid Balance In Hypoxemic and High Extravascular 
Lung Water Patients. Intensive Care Medicine 2011;37(S1):0370 
• Duplicate / overlap 
 
Dulhunty et al.  Increased Fluid Resuscitation Can Lead To Adverse Outcomes In Major-Burn Injured 
Patients, But Low Mortality Is Achievable. Burns 2008;34:1090-1097 
• Resuscitation phase study 
 
Early Goal-Directed Therapy Collaborative Group of Zhejiang.  The Effect of Early Goal-Directed 
Therapy On Treatment of Critical Patients With Severe Sepsis/Septic Shock: A Multi-Center, 
Prospective, Randomized, Controlled Study.  Chinese Critical Care Medicine 2010;22:331-334 
• Resuscitation phase study 
 
Eisenberg et al.  A Prospective Study of Lung Water Measurements During Patient Management In An 
Intensive Care Unit.  Am Rev Respir Dis 1987;136:662-668 
• Fluid balance not reported 
• Study population did not match criteria 
El-Akabawy et al.  The Concept of Early Goal-Directed Therapy In Sepsis Syndrome.  Intensive Care 
Medicine 2011;37(S1):0439 
• Complex haemodynamic intervention 
• Resuscitation phase study 
Finfer et al.    A Comparison of Albumin and Saline For Fluid Resuscitation In The Intensive Care Unit.  
The New England Journal of Medicine 2004;350:2247-2256 
• Fluid type study 
 
Finfer et al.  Impact of Albumin Compared To Saline On Organ Function and Mortality of Patients With 
Severe Sepsis.  Intensive Care Medicine 2011;37:86-96 
• Fluid type study 
• Duplicate / overlap 
 
Flori et al.  Positive Fluid Balance Is Associated With Higher Mortality and Prolonged Mechanical 
Ventilation In Pediatric Patients With Acute Lung Injury.  Critical Care Research and Practice 
2011:854142 
• Duplicate / overlap 
 
 57 
Garcia Olivares et al.  Clinical Implication of Resuscitation With Fluids Guided By Central Venous 
Pressure In Septic Shock.  Intensive Care Medicine 2010;36(S1):1349 
• Resuscitation phase study 
 
Gardner et al.  Faster Rate of Initial Fluid Resuscitation In Severe Acute Pancreatitis Diminishes In-
Hospital Mortality.  Pancreatology 2009;9:770-779. 
• Observational study with n<50 
 
Gomez et al.   Late Fluid Management and Risk of Respiratory Failure In Septic Patients.  American 
Journal of Respiratory and Critical Care Medicine 2009:179:A4730 
• Resuscitation phase study 
 
Grams et al.  Fluid Balance, Diuretic Use, and Mortality In Acute Kidney Injury.  Clinical Journal of The 
American Society of Nephrology: CJASN 2011;6:966-973 
• Duplicate / overlap 
Grams et al.  Fluid Balance, Diuretic Use, and Mortality In Acute Kidney Injury.  Clinical Journal of The 
American Society of Nephrology: CJASN 2011;6:966-973 
• Duplicate / overlap 
 
Grissom et al.  Retrospective Comparison of A Simpler Modified Fluid Conservative Protocol With The 
Original Factt Fluid Conservative Protocol In The ARDS Network.  American Journal of Respiratory and 
Critical Care Medicine 2013;187:A4482 
• Duplicate / overlap 
 
Grissom et al.  Retrospective Comparison of A Simpler Modified Fluid Conservative Protocol With The 
Original Factt Fluid Conservative Protocol In The ARDS Network.  American Journal of Respiratory and 
Critical Care Medicine 2013;187:A4482 
• Duplicate / overlap 
 
Gu et al.  Effect of Fluid Resuscitation On Extravascular Lung Water In Early Stage of Septic Shock. 
Chinese Critical Care Medicine 2007;19:283-286 
• Resuscitation phase study 
• Observational study with n<50 
Guidet et al.  Assessment of Hemodynamic Efficacy and Safety of 6% Hydroxyethylstarch 130/0.4 Vs. 
0.9% NaCl Fluid Replacement In Patients With Severe Sepsis: The CRYSTMAS Study.  Critical Care 
2012;16:R94 
• Fluid type study 
 
Guidet et al.  Assessment of Hemodynamic Efficacy and Safety of 6% Hydroxyethylstarch 130/0.4 Vs. 
0.9% NaCl Fluid Replacement In Patients With Severe Sepsis: The CRYSTMAS Study.  Critical Care 
2012;16:R94 
• Fluid type study 
 
• Duplicate / overlap 
 
Heung et al.  Fluid Overload At Initiation of Renal Replacement Therapy Is Associated With Lack of 
Renal Recovery In Patients With Acute Kidney Injury. Nephrology Dialysis Transplantation 2012:27:956-
961 
• Study population did not match criteria 
 
Hjortrup et al.  Patient and Site Characteristics and Volumes of Resuscitation Fluids In Severe Sepsis-A 
Post Hoc Analysis of A Randomised Clinical Trial.  Intensive Care Medicine 2014;40(S1):0779 
• Clinical outcomes of interest not reported 
 
Hou et al.  Positive Fluid Balance Worsens Clinical Outcomes For Hospitalized Pneumonia Patients.  
American Journal of Respiratory and Critical Care Medicine 2013;187:A5985 
• Study population did not match criteria 
• Resuscitation phase study 
 58 
Hu et al.  Extravascular Lung Water and Pulmonary Arterial Wedge Pressure For Fluid Management In 
Patients With Acute Respiratory Distress Syndrome.  Multidisciplinary Respiratory Medicine 2014;9(1):3 
• Study population did not match criteria 
Hunter et al.  Fluid Creep In Colloid Resuscitated Burns Patients: Is Less More?  Burns 2009;35:S14 • Clinical outcomes of interest not reported 
Jacob et al.  Severe Sepsis In Two Ugandan Hospitals: A Prospective Observational Study of 
Management and Outcomes In A Predominantly HIV-1 Infected Population. PLoS One 2009;4:E7782 
• Resuscitation phase study 
Jelenko et al.  Shock and Resuscitation. Ii: Volume Repletion With Minimal Edema Using The 
HALFD(Hypertonic Albuminated Fluid Demand) Regimen.  Jacep 1978;7:326-333. 
• Pre-1980 
• Fluid type study 
Jelenko et al.  Studies In Shock and Resuscitation, I: Use of A Hypertonic, Albumin-Containing, Fluid 
Demand Regimen (HALFD) In Resuscitation. Critical Care Medicine 1979;7:157-167 
• Pre-1980 
• Fluid type study 
Jelenko et al.  Shock and Resuscitation Ii: Volume Repletion With Minimal Edema Using The 'Halfd' 
Method.  Journal of The American College of Emergency Physicians 1978;7:326-333 
• Pre-1980 
 
• Fluid type study 
Jog et al.  Stroke Volume Variation-Guide To Fluid Therapy In Septic Shock With ARDS.  Intensive Care 
Medicine 2009; 35(S1):0098 
• Observational study with n<50 
 
Jog et al.  Stroke Volume Variation Guided Fluid Therapy In Septic Shock With ARDS. Critical Care 
2012;16(S1):P233 
• Observational study with n<50 
Jog et al.  Stroke Volume Variation Guided Fluid Therapy In Severe Septic Shock: When To Stop 
Chasing High SVV? Intensive Care Medicine 2013;39(S2):0084 
• Observational study with n<50 
 
Jones et al.  Prospective External Validation of The Clinical Effectiveness of An Emergency Department-
Based Early Goal-Directed Therapy Protocol For Severe Sepsis and Septic Shock.  Chest 
2007;132:425-432 
• Resuscitation phase study 
 
• Complex haemodynamic intervention 
Jones et al.  Lactate Clearance Versus Central Venous Oxygen Saturation As Endpoints of Early Sepsis 
Therapy: A Randomized Clinical Trial.  Critical Care Medicine 2009; 37(12 Supp.):49 
• Resuscitation phase study 
 
Juneja et al.  Use of Stroke Volume Variation To Guide Fluid Therapy In Septic Shock For Prevention of 
Acute Kidney Injury.  Intensive Care Medicine 2009;35(S1):0104 
• Fluid balance not reported 
Kalra et al.  Fluid Balance At 72 Hours In Severe Sepsis and Septic Shock Patients Treated With Early 
Goal-Directed Therapy (EGDT) Is Associated With Increased Length of Mechanical Ventilation.  Chest 
2010;138 (4):A388 
• Fluid balance not reported 
Kanji et al.  Limited Echocardiography-Guided Therapy In Subacute Shock Is Associated With Change In 
Management and Improved Outcomes.  Journal of Critical Care 2014;29:700-705 
• Complex haemodynamic intervention 
 
 59 
Katsaragakis et al.  Rapid Fluid Removal Via Continuous Venovenous Hemodiafiltration and Oxygen 
Delivery, Oxygen Consumption, and Outcome In Septic Patients With Renal Dysfunction.  Dialysis and 
Transplantation 2005;34:608-615 
• Observational study with n<50 
 
Kaufman et al.  Fluid Resuscitation In Circulatory Shock. Colloids Versus Crystalloids.  Current Studies 
In Hematology & Blood Transfusion 1986:186-198 
• Not original study 
Kelm et al.  The Potential Burdens of Fluid Overload In Patients With Septic Shock.  American Journal of 
Respiratory and Critical Care Medicine 2013;187:A3063 
• Duplicate / overlap 
 
Kelm et al.  Fluid Overload In Patients With Severe Sepsis and Septic Shock Treated With Early Goal-
Directed Therapy Is Associated With Increased Aute Need For Fluid-Related Medical Interventions and 
Hospital Death.  Shock  
2015;43(1):68-73 
• Duplicate / overlap 
 
Kelm et al.  Fluid Overload In Patients With Severe Sepsis and Septic Shock Treated With Early Goal-
Directed Therapy Is Associated With Increased Acute Need For Fluid-Related Medical Interventions and 
Hospital Death.  Shock 2015;43:68-73 
• Fluid balance not reported 
Kiers et al.  Early Goal-Directed Therapy of Septic Patients Coming From The Ward Does Not Protect 
The Kidneys.  Critical Care 2009;13(S1):P259 
• Resuscitation phase study 
 
• Duplicate / overlap 
Kiers et al.  Effect of Early Achievement of Physiologic Resuscitation Goals In Septic Patients Admitted 
From The Ward On The Kidneys. Journal of Critical Care 2010;25:563-569 
• Resuscitation phase study 
 
Kim et al. A Positive Fluid Balance and Used Loop Diuretics Amount Are Associated Increased Mortality 
In Intensive Care Unit.  Intensive Care Medicine 2012;38(S1):0911 
• Study population did not match criteria 
 
Klein et al.  The Association Between Fluid Administration and Outcome Following Major Burn: A 
Multicenter Study.  Annals of Surgery 2007;245:622-628 
• Resuscitation phase study 
 
Koonrangsesomboon and Khwannimit. Positive Fluid Balance and Prognostic Factors of ICU Mortality In 
Patients Admitted With Septic Shock. Critical Care 2014;18(S2):P70 
• Study population did not match criteria 
 
Kraft et al.  Outcomes of Optimized Fluid Resuscitation After Severe Burn Injury Utilizing Hemodynamic 
Measurements By Transpulmonary Thermodilution.  Surgical Infections 2011;12:S16-S17 
• Fluid balance not reported 
 
• Resuscitation phase study 
Krausz et al.  Cardiopulmonary Effects of Volume Loading In Patients In Septic Shock. Annals of Surgery 
1977;185:429-434 
• Observational study with n<50  
• Pre-1980 
• Clinical outcomes of interest not reported 
 60 
Lau et al.  Fluid Management For Shock In The First 24 Hours of Intensive Care Unit Stay: Impact of A 
Simple Clinical Protocol.  Annals of The Academy of Medicine Singapore 2014;1:S319 
• Resuscitation phase study 
 
Lechliter and Shibli.  Impact of Fluid Management Strategies In Patients With Acute Respiratory Distress 
Syndrome (ARDS).  Chest 2009;136(S4):S77 
• Observational study with n<50 
 
Lee et al.  Association Between Fluid Balance and Survival In Critically Ill Patients.  Journal of Internal 
Medicine 2015;277(4):468-77 
• Study population did not match criteria 
Lee et al.  Association Between Fluid Balance and Survival In Critically Ill Patients.  Journal of Internal 
Medicine 2015;277(4):468-77 
• Study population did not match criteria 
Lee et al.  Is Fluid Administration Within Six Hours Early Enough For Better Patient Outcomes In Sepsis 
and Septic Shock?  Critical Care Medicine 2012;40(12):26 
• Resuscitation phase study 
 
Lee et al.  Increased Fluid Administration In The First Three Hours of Sepsis Resuscitation Is Associated 
With Reduced Mortality: A Retrospective Cohort Study.  Chest 2014;146:908-915 
• Resuscitation phase study 
 
Legrand et al. A Role of Renal Venous Congestion In Septic Acute Kidney Injury?  Intensive Care 
Medicine 2011;37(S1):0968 
• Fluid balance not reported 
Lin et al.  A Modified Goal-Directed Protocol Improves Clinical Outcomes In Intensive Care Unit Patients 
With Septic Shock: A Randomized Controlled Trial.  Shock 2006;26:551-557 
• Resuscitation phase study 
• Complex haemodynamic intervention 
Liu et al.  Acute Kidney Injury In Patients With Acute Lung Injury: Impact of Fluid Accumulation On 
Classification of Acute Kidney Injury and Associated Outcomes.  Critical Care Medicine 2011; 39:2665-
2671 
• Duplicate / overlap 
 
Lobo and Cunha.  Time To Recover From Shock Is Determinant of A Positive Fluid Balance In Septic 
Shock. Critical Care 2013:17(S2):P238 
• Observational study with n<50 patients.  
Lobo and Cunha.  Time To Recover From Shock Is Determinant of A Positive Fluid Balance In Septic 
Shock.  Critical Care 2013; 17(S2):P238 
• Duplicate / overlap 
Lyu et al.  Efficacies of Fluid Resuscitation As Guided By Lactate Clearance Rate and Central Venous 
Oxygen Saturation In Patients With Septic Shock. National Medical Journal of China 2015;95: 496-500 
• Resuscitation phase study 
 
Mahrous et al. Renal Effect of Colloid Versus Crystalloid In Septic Neutropenic Patients. Critical Care 
Medicine 2013;41(12 S1):996 
• Fluid type study 
 
Maitland et al.  Mortality After Fluid Bolus In African Children With Severe Infection.  The New England 
Journal of Medicine 2011;364:2483-2495 
• Resuscitation phase study 
 
 61 
Maitland et al.  Exploring Mechanisms of Excess Mortality With Early Fluid Resuscitation: Insights From 
The FEAST Trial.  BMC Medicine 2013;11:Pp 
• Resuscitation phase study 
 
Mao et al.  Therapeutic Experience of Fulminant Acute Pancreatitis In Acute Response Stage. Chinese 
Journal of Surgery 2006;44:1185-1188 
• Not relevant 
Mao et al.  Fluid Therapy For Severe Acute Pancreatitis In Acute Response Stage. Chinese Medical 
Journal 2009;122:169-173 
• Resuscitation phase study 
Martin. Fluid Balance and Colloid Osmotic Pressure In Acute Respiratory Failure: Emerging Clinical 
Evidence.  Critical Care 2000;4:S21-S25 
• Not original study 
Mcintyre et al.  Resuscitating Patients With Early Severe Sepsis: A Canadian Multicentre Observational 
Study.  Canadian Journal of Anaesthesia 2007;54:790-798 
• Resuscitation phase study 
 
Mitchell et al.  Volume Overload: Prevalence, Risk Factors, and Functional Outcome In Survivors of 
Septic Shock. Annals of The American Thoracic Society 2015;12(12):1837-44 
• Clinical outcomes of interest not reported 
Mitchell et al.  Fluid Management of Sepsis After Shock Resolution: An Analysis of Intensive Care Unit 
Volume Status In Relation To Mobility On Hospital Discharge.  American Journal of Respiratory and 
Critical Care Medicine 2013;187:A3951 
• Duplicate / overlap 
 
Mitchell et al.  Fluid Management of Sepsis After Shock Resolution: An Analysis of Practice Variation and 
Risk Factors.  American Journal of Respiratory and Critical Care Medicine 2012;185:A1124 
• Duplicate / overlap 
 
Morisawa et al.  Combined Use of Transpulmonary Thermodilution Technique In Fluid Management For 
Sepsis Patients.  Intensive Care Medicine 2014;40(S1):0147 
• Observational study with n<50 
 
Mouncey et al.  Trial of Early, Goal-Directed Resuscitation For Septic Shock.  New England Journal of 
Medicine 2015;372:1301-1311 
• Complex haemodynamic intervention 
• Resuscitation phase study 
Muller et al.  Fluid Management and Risk Factors For Renal Dysfunction In Patients With Severe Sepsis 
and/Or Septic Shock. Critical Care 2012;16:R34 
• Fluid type study 
 
Ngo et al.  Acute Management of Dengue Shock Syndrome: A Randomized Double-Blind Comparison of 
4 Intravenous Fluid Regimens In The First Hour.  Clinical Infectious Diseases 2001; 32:204-213 
• Resuscitation phase study 
 
Nogueira et al.  Positive Daily Fluid Balance As An Independent Predictor of Mortality In Critically Ill 
Patients. Intensive Care Medicine 2013;39(S2):0250 
• Study population did not match criteria 
 
Oliveira et al.   Early and Late Positive Fluid Balance In Sepsis: Are They Both Related To Mortality and 
Acute Kidney Injury? Critical Care Medicine 2011;12(S1):56 
• Duplicate / overlap 
 
Oliveira et al.  Early and Late Positive Fluid Balance In Sepsis: Are They Both Related To Mortality and 
Acute Kidney Injury?  Critical Care Medicine 2011;12(S1):56 
• Duplicate / overlap 
 62 
Olupot-Olupot.  Fluid Expansion As Supportive Therapy (Feast) Trial: Mortality After Fluid Bolus In 
African Children.  Tropical Medicine and International Health 2012;17:43 
• Not original study 
Orbegozo et al. Colloids For Fluid Resuscitation: What Is Their Role In Patients With Shock? Minerva 
Anestesiologica 2014;80:963-969 
• Fluid type study 
Ozuzun et al.   Early Fluid Resuscitation of End Stage Renal Disease Patients With Severe Sepsis and 
Septic Shock. Critical Care Medicine 2014;42(12):923 
• Resuscitation phase study 
 
Park et al.  Early Cumulative Fluid Balance and Development of Acute Lung Injury.  American Journal of 
Respiratory and Critical Care Medicine 2011;183:A5592 
• Study population did not match criteria 
 
Patolia et al.  Predicting Clinical Deterioration In Severe Sepsis Patients With Cryptic Shock.  Intensive 
Care Medicine 2014;40(S1):1025 
• Resuscitation phase study 
 
Payen et al.    A Positive Fluid Balance Is Associated With A Worse Outcome In Patients With Acute 
Renal Failure. Critical Care 2008;12:R74 
• Study population did not match criteria 
 
Pereira et al.  Impact of Fluid Balance To Organ Dysfunction In Critically Ill Patients. Critical Care 
2016;20:P171 
• Study population did not match criteria 
Perez-Fernandez et al.  Fluid Balance On Early Stages of Septic Shock Patients With Continuous Renal 
Replacement Techniques.  Intensive Care Medicine 2011;37(S1):0970 
• Duplicate / overlap 
Permpikul et al.  Impact of Septic Shock Hemodynamic Resuscitation Guidelines On Rapid Early Volume 
Replacement and Reduced Mortality.  Journal of The Medical Association of Thailand 2010; 93 
(S1):S102-S109 
• Resuscitation phase study 
 
Perner et al. Long-Term Outcomes In Patients With Severe Sepsis Randomised To Resuscitation With 
Hydroxyethyl Starch 130/0.42 Or Ringer's Acetate. Intensive Care Medicine 2014;40:927-934 
• Fluid type study 
Phillips et al.  Crystalloids Vs. Colloids: Ko At The Twelfth Round?  Critical Care 2013;17:319 • Fluid type study 
Puffinbarger et al.  Rapid Isotonic Fluid Resuscitation In Pediatric Thermal Injury.  Journal of Pediatric 
Surgery 1994;29:339-342 
• Resuscitation phase study 
 
Puskarich et al.  One Year Mortality of Patients Treated With An Emergency Department Based Early 
Goal Directed Therapy Protocol For Severe Sepsis and Septic Shock: A Before and After Study. Critical 
Care 2009;13:R167 
• Resuscitation phase study 
 
• Complex haemodynamic intervention 
Raimundo et al.  Impact of Fluid Balance In The Outcome of Septic Critically Ill Patients.  Intensive Care 
Medicine 2012;38(S1):0696 
• Duplicate / overlap 
Recinos et al.  Fluid Resuscitation of Burn Patients Comparing A Crystalloid With A Colloid Containing 
Solution: A Prospective Study.  Journal of The Iowa Medical Society 1975;65:426-432 
• Pre-1980 
 
 63 
• Fluid type study 
Reddy et al.   Furosemide Infusion In Children With Dengue Fever and Hypoxemia.  Indian Pediatrics 
2014;51:303-305 
• Fluid balance not reported 
Richard et al. Preload-Dependence Indices To Titrate Volume Expansion During Septic Shock: A 
Randomized Controlled Trial. Intensive Care Medicine 2014;40(S1):0881 
• Duplicate / overlap 
Richard et al. Preload-Dependence Indices To Titrate Volume Expansion During Septic Shock: A 
Randomized Controlled Trial. Intensive Care Medicine 2014;40(S1):0881 
• Duplicate / overlap 
Rinaldi et al.  Effectiveness of Sepsis Bundle Application In Cirrhotic Patients With Septic Shock: A 
Single-Center Experience.  Journal of Critical Care 2013;28:152-157 
• Resuscitation phase study 
• Observational study with n<50 
Rinka et al.   Fluid Therapy In Patients With Severe Sepsis After The Earliest Phases of Treatment. 
Critical Care Medicine 2009: 37(12):913 
• Fluid balance not reported 
Rinka et al.  Fluid Therapy In Patients With Severe Sepsis After The Earliest Phases of Treatment.  
Critical Care Medicine 2009;37(12 S1): 913 
• Duplicate / overlap 
Rivers et al.  Early Goal-Directed Therapy In The Treatment of Severe Sepsis and Septic Shock.  The 
New England Journal of Medicine 2001;345:1368-1377 
• Resuscitation phase study 
• Complex haemodynamic intervention 
Sabater et al.  Diuretics In Septic Acute Renal Failure Needing Continuous Renal Replacement 
Therapies.  Intensive Care Medicine 2011;37(S1):0977 
• Fluid balance not reported 
Sadaka et al.  Fluid Resuscitation In Septic Shock: The Effect of Increasing Fluid Balance On Mortality. 
Critical Care Medicine 2012;40(12 S1):533 
• Resuscitation phase study 
Sadaka et al.  Fluid Resuscitation In Septic Shock: The Effect of Increasing Fluid Balance On Mortality.  
Critical Care Medicine 2012;40(12 S1):533 
• Resuscitation phase study 
 
• Duplicate / overlap 
Sadaka et al.  Fluid Resuscitation In Septic Shock: The Effect of Increasing Fluid Balance On Mortality.  
Journal of Intensive Care Medicine 2014;29:213-217. 
• Resuscitation phase study 
 
Saito et al.  Implementation of An Optimal Fluid Management Protocol Using The PICCO System Delays 
Development of ARDS Secondary To Severe Sepsis.  Critical Care 2012;16(S1):P243 
• Duplicate / overlap 
 
Sakr et al.  High Tidal Volume and Positive Fluid Balance Are Associated With Worse Outcome In Acute 
Lung Injury.  Chest 2005;128:3098-3108. 
• Duplicate / overlap 
Sammani et al.  Positive Fluid Balance Is A Risk Factor For Acute Kidney Injury In Critically Ill Patients.  
Critical Care Medicine 2014;42(12 S1):928 
• Study population did not match criteria 
 
 64 
Samransamruajkit et al.  A Comparison of NSS vs Balanced Salt Solution As A Fluid Resuscitation and 
Impact of Fluid Balance On Clinical Outcomes In Pediatric Septic Shock. American Journal of 
Respiratory and Critical Care Medicine 2015;191:A4072 
• Observational study with n<50  
Santhanam et al.  A Prospective Randomized Controlled Study of Two Fluid Regimens In The Initial 
Management of Septic Shock In The Emergency Department.  Pediatric Emergency Care 2008;24:647-
655 
• Fluid type study 
 
Schwab et al.  Standard Operating Procedure In Patients With Severe Sepsis and Septic Shock.  Critical 
Care 2009;13(S1):P343 
• Resuscitation phase study 
 
Seymour et al.  Prehospital Intravenous Access and Fluid Resuscitation In Severe Sepsis: An 
Observational Cohort Study.  Critical Care 2014;18:533 
• Resuscitation phase study 
 
Shimazaki et al.  Fluid Distribution and Pulmonary Dysfunction Following Burn Shock.  Journal of 
Trauma-Injury Infection & Critical Care 1991;31:623-626 
• Duplicate / overlap 
Silversides et al.  Fluid Balance and Renal Outcomes In Patients Requiring Renal Replacement Therapy 
In The ICU. Critical Care 2013;17(S2):P434 
• Study population did not match criteria 
Sirvent et al.  Fluid Balance In Sepsis and Septic Shock As A Determining Factor of Mortality.  American 
Journal of Emergency Medicine 2015;33:186-189 
• Observational study with n<50 
 
Sirvent et al.  Fluid Balance In Sepsis and Septic Shock As A Determining Factor of Mortality.  The 
American Journal of Emergency Medicine.  2015;33(2):186-9 
• Observational study with n<50  
• Duplicate / overlap 
Sivayoham et al.  Outcomes From Implementing Early Goal-Directed Therapy For Severe Sepsis and 
Septic Shock : A 4-Year Observational Cohort Study. European Journal of Emergency Medicine 
2012;19:235-240 
• Resuscitation phase study 
 
Smith and Perner.  Lower Mortality With Higher Fluid Volume In Patients With Persisting Septic Shock. 
Critical Care 2011:37(S1):905 
• Duplicate / overlap 
Smith et al.  Higher Vs. Lower Fluid Volume For Septic Shock: Clinical Characteristics and Outcome In 
Unselected Patients In A Prospective, Multicenter Cohort.  Critical Care 2012;16:R76 
• Duplicate / overlap 
 
Somasetia et al.  Early Resuscitation of Dengue Shock Syndrome In Children With Hyperosmolar 
Sodium-Lactate: A Randomized Single-Blind Clinical Trial of Efficacy and Safety. Critical Care 
2014;18:466 
• Resuscitation phase study 
 
• Fluid type study 
 
Sterling et al.  The Effect of Early Quantitative Resuscitation On Organ Function In Survivors of Septic 
Shock.  Journal of Critical Care 2015;30:261-263 
• Resuscitation phase study 
 
 65 
Stewart et al.  Less Is More: Improved Outcomes In Surgical Patients With Conservative Fluid 
Administration and Central Venous Catheter Monitoring.  Journal of The American College of Surgeons 
2009; 208:725-735 
• Duplicate / overlap 
 
Stewart et al.  Less Is More: Improved Outcomes In Surgical Patients With Conservative Fluid 
Administration and Central Venous Catheter Monitoring.  Journal of The American College of Surgeons 
2009;208:725-735 
• Duplicate / overlap 
 
Sun et al.  The Clinical Application of Pulse Indicator Continuous Cardiac Output Monitoring In Early 
Fluid Resuscitation For Patients With Severe Acute Pancreatitis.  Zhonghua Wei Zhong Bing Ji Jiu Yi 
Xue 2014;26:571-575 
• Observational study with n<50 
 
Toy et al.  Transfusion-Related Acute Lung Injury: Incidence and Risk Factors.  Blood 2012;119:1757-
1767 
• Not relevant 
Trof et al.  Volume-Versus Pressure-Guided Hemodynamic Management In The Critically Ill Septic and 
Non-Septic Patient: Transpulmonary Thermodilution With PICCO Technology Versus Pulmonary Artery 
Catheter.  Intensive Care Medicine 2010; 36(S1):1052 
• Resuscitation phase study 
 
Trof et al.  Volume-Limited Versus Pressure-Limited Hemodynamic Management In Septic and 
Nonseptic Shock.  Critical Care Medicine 2012;40:1177-1185 
• Resuscitation phase study 
 
Uchino et al.  Pulmonary Artery Catheter Versus Pulse Contour Analysis: A Prospective Epidemiological 
Study. Critical Care 2006;10:R174 
• Study population did not match criteria 
 
Vaara et al.  Fluid Overload Is Associated With An Increased Risk For 90-Day Mortality In Critically Ill 
Patients With Renal Replacement Therapy: Data From The Prospective Finnaki Study.  Critical Care 
2012;16:R197 
• Study population did not match criteria 
 
Valentine et al.  Fluid Balance In Critically Ill Children With Acute Lung Injury Approximates The 
ARDSnet Fluid and Catheter Treatment Trial (Factt) Liberal Fluid Protocol and Is Associated With A 
Longer Duration of Mechanical Ventilation. American Journal of Respiratory and Critical Care Medicine 
2011;183:A6280 
• Duplicate / overlap 
 
Van Biesen et al.  Relationship Between Fluid Status and Its Management On Acute Renal Failure (Arf) 
In Intensive Care Unit (ICU) Patients With Sepsis: A Prospective Analysis. Journal of Nephrology 
2005;18:54-60 
• Fluid balance not reported 
Van Genderen et al.  Early Peripheral Perfusion Targeted Fluid Therapy Leads To Less Fluid 
Administration In Patients With Septic Shock: A Prospective Randomized Controlled Trial. Intensive Care 
Medicine 2014:40(S1):0452 
• Resuscitation phase study 
 
Van Der Voort et al. Testing A Conceptual Model On Early Opening of The Microcirculation In Severe 
Sepsis and Septic Shock: A Randomised Controlled Pilot Study.  European Journal of Anaesthesiology 
2015;32:189-198 
• Complex haemodynamic intervention 
 
 66 
Vladimir and Niksa .  Delivery Dependent Oxygen Consumption In Patients With ARDS: Relationship 
Between Volume Loading and Outcome.  Clinical Intensive Care 1992;3:42 
• Observational study with n<50 
 
Waechter et al.   Early Administration of Crystalloid Fluids Reduces Mortality In Septic Shock. American 
Journal of Respiratory and Critical Care Medicine 2010;181:A4097 
• Resuscitation phase study 
 
Waechter et al.  Interaction Between Fluids and Vasoactive Agents On Mortality In Septic Shock: A 
Multicenter, Observational Study.  Critical Care Medicine 2014;42:2158-2168 
• Resuscitation phase study 
 
Warndorf et al.  The Effect of Early Aggressive Fluid Resuscitation On Morbidity and Mortality In Acute 
Pancreatitis. Gastroenterology 2011;140(5):S13 
• Study population did not match criteria 
 
Wiedemann et al.  Comparison of Two Fluid-Management Strategies In Acute Lung Injury.  The New 
England Journal of Medicine 2006;354:2564-2575 
• Duplicate / overlap 
 
Williams et al.  Implementation of Early Goal-Directed Therapy For Children With Suspected Sepsis: 
Minimizing Unnecessary Variation and Maximizing Benefit. Critical Care Medicine 2010;38(12 S1):62 
• Resuscitation phase study 
 
• Complex haemodynamic intervention 
Yan.  The Effect of Early Goal-Directed Therapy On Treatment of Critical Patients With Severe 
Sepsis/Septic Shock: A Multi-Center, Prospective, Randomized, Controlled Study.  Chinese Critical Care 
Medicine 2010;22:331-334 
• Complex haemodynamic intervention 
 
• Resuscitation phase study 
Yang et al.   Effects of Early Goal-Directed Fluid Therapy on Intra-abdominal Hypertension and Multiple 
Organ Dysfunction in Patients with Severe Acute Pancreatitis.  Chinese Journal of Surgery 
2009;47:1450-1454 
• Fluid type study 
Yu et al.  Comparison of The Effect of Fluid Resuscitation As Guided Either By Lactate Clearance Rate 
Or By Central Venous Oxygen Saturation In Patients With Sepsis. Chinese Critical Care Medicine 
2013;25(10):578-583 
• Study population did not match criteria 
 
Yu et al.  Comparison of The Effect of Fluid Resuscitation As Guided Either By Lactate Clearance Rate 
Or By Central Venous Oxygen Saturation In Patients With Sepsis. Chinese Critical Care Medicine 
2013;25(10):578-583 
• Study population did not match criteria 
 
Zhang et al.  Comparative Study On The Effect of Restrictive Fluid Management Strategy On The Early 
Pulmonary Function of Patients With Severe Burn. Chinese Journal of Burns 2012;28:165-169 
• Observational study with n<50  
Zhang et al.  The Influence of Volume Load On Prognosis of Patients With Sepsis Induced Acute Kidney 
Injury.  Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2013;25:411-414 
• Duplicate / overlap 
 
Zhang et al. Effectiveness of Treatment Based On PICCO Parameters In Critically Ill Patients With Septic 
Shock and/Or Acute Respiratory Distress Syndrome: A Randomized Controlled Trial.  Intensive Care 
Medicine 2015;41:444-451 
• Duplicate / overlap 
 
 67 
Zhao et al.  Effects of Different Resuscitation Fluid On Severe Acute Pancreatitis.  World Journal of 
Gastroenterology 2013;19:2044-2052 
• Fluid type study 
Zhi et al.  Influence of Fluid Loading In Patients At Different Stages of Septic Shock: A Prospective 
Study.  Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2015;27:13-16 
• Observational study with n<50 
 
Zhu et al.  The Study of Hypertonic Saline and Hydroxyethyl Starch Treating Severe Sepsis. Chinese 
Critical Care Medicine 2011;23:150-153 
• Fluid type study 
 
 
